See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Join us! · SLAS2012 1st Annual Conference & Exhibition · San Diego, California · February 4-8, 2012 · Booth 445

Research Area · Atherosclerosis

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
19500 11-dehydro Thromboxane B2 67910-12-7 ≥98% 51.338044198895 11-dehydro-thromboxane-b2 11-keto TXB2; 11-dehydro TXB2 metabolites thromboxanes plasma 11-dehydro-TXB2 11-keto-TXB2 atherosclerosis 51.338044198895
319500 11-dehydro Thromboxane B2-d4 - ≥99% deuterated product 22.949627071823 11-dehydro-thromboxane-b2-d4 11-keto TXB2-d4 GC/MS deuterium isotopes 11-dh-TXB2-d4 internal standards thromboxanes 11-dehydro-TXB2-d4 deuterated GC-MS LC/MS LC-MS mass spectrometry atherosclerosis 22.949627071823
519501 11-dehydro Thromboxane B2 EIA Kit - 305.502399368587 11-dehydro-thromboxane-b2-eia-kit 11-dehydro Thromboxane B2 ELISA Kit solid plates 11-dehydro-TXB2 enzyme immunoassays ELISAs kits measures atherosclerosis metabolites thromboxanes eias atherosclerosis assays 305.502399368587
10007239 11-dehydro Thromboxane B2 Lipid Maps MS Standard 67910-12-7 ≥98% 2009-01-16 13.425990528808 11-dehydro-thromboxane-b2-lipid-maps-ms-standard 11-dehydro TXB2; 11-keto TXB2 metabolites thromboxanes plasma 11-dehydro-TXB2 11-keto-TXB2 atherosclerosis MS mass spectrometry standards 13.425990528808
10006831 11-dehydro Thromboxane B2 Quant-PAK - 2005-08-08 19.168821362799 11-dehydro-thromboxane-b2-quant-pak Quant-PAKs metabolites thromboxanes plasma deuterium isotopes 11-dh-TXB2-d4 internal standards 11-dehydro-TXB2-d4 deuterated GC/MS GC-MS LC/MS LC-MS mass spectrometry atherosclerosis packs 19.168821362799
160304 12-Lipoxygenase (murine leukocyte) Polyclonal Antiserum - 52.977651933701 12-lipoxygenase-murine-leukocyte-polyclonal-antiserum 12-LO; 12-LOX 12-LOs leukocyte 12-lipoxygenases western blots blotting WB antisera antibodies antiserum atherosclerosis immunoblotting 52.977651933701
34590 12(S)-HHTrE 54397-84-1 ≥97% 50.623554327808 12-s-hhtre 12(S)-HHT platelets thromboxanes hydroxy acids 12S-HHTrEs 12-HHTrEs fatty atherosclerosis 12(s)-hhtre 12(s)-hhtre 50.623554327808
10007250 12(S)-HHTrE Lipid Maps MS Standard 54397-84-1 ≥97% 2009-02-26 34.115911602210 12-s-hhtre-lipid-maps-ms-standard 12-HHT platelets thromboxanes hydroxy acids 12S-HHTrEs 12-HHTrEs fatty atherosclerosis MS mass spectrometry standards 34.115911602210
10010425 13,14-dihydro-15-keto Prostaglandin D1 Exclusive - >98% ✓ 2008-05-09 0.494944751381 13-14-dihydro-15-keto-prostaglandin-d1 13,14-dihydro-15-keto PGD1 PGD1 prostaglandins metabolites DGLA dihomo-.gamma.-linolenic acid dihomo-gamma-linolenic dihomo-y-linolenic PGDs pathways 0.494944751381
38601 (±)13-HODE cholesteryl ester 167354-91-8 ≥98% 7.234622467771 -13-hode-cholesteryl-ester atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids (+/-)13-HODEs esters racemic 7.234622467771
10704 (±)13-HpODE 23017-93-8 ≥98% 2011-02-24 43.268356353591 -13-hpode hydroperoxides lipids linoleic acids reactive oxygen species oxidative stress injury 43.268356353591
38606 13(R)-HODE cholesteryl ester - ≥98% 1.207274401473 13-r-hode-cholesteryl-ester atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids 13-HODEs 13R-HODEs esters 1.207274401473
38611 13(S)-HODE cholesteryl ester - ≥98% 15.777569060773 13-s-hode-cholesteryl-ester atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids 13-HODEs 13S-HODEs esters 13(S)HODEs 13(S)-HODEs 15.777569060773
39620 13(S)-HOTrE 87984-82-5 ≥98% 4.362099447513 13-s-hotre linolenic acids hydroxy metabolites 13S-HOTrEs 13-HOTrEs fatty 13(S)-HOTrEs 13(S)HOTrEs 4.362099447513
48610 13(S)-HpODE 33964-75-9 >98% 90.115230202578 13-s-hpode linoleic hydroperoxides 13S-HpODEs 13-HpODEs hydroperoxy fatty acids 13(S)-HpODEs 90.115230202578
18570 15-deoxy-Δ12,14-Prostaglandin J2 87893-55-8 ≥95% 158.281875383670 15-deoxy-12-14-prostaglandin-j2 15-deoxy-Δ12,14-PGJ2 PPARγ PPARgamma prostaglandins 15-deoxy-delta12,14-PGJ2 15-deoxy-d12,14-PGJ2 nuclear receptors 15-deoxy-Δ12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands 15dpgj2 atherosclerosis 158.281875383670
318570 15-deoxy-Δ12,14-Prostaglandin J2-d4 - ≥99% deuterated product 45.062850828729 15-deoxy-12-14-prostaglandin-j2-d4 15-deoxy-Δ12,14-PGJ2-d4 GC/MS deuterium isotopes 15-deoxy-DELTA12,14-PGJ2-d4 15-deoxy-.DELTA.12,14-PGJ2-d4 15-deoxy-D12,14-PGJ2-d4 internal standards prostaglandins deuterated mass spectrometry GC-MS LC-MS LC/MS atherosclerosis 45.062850828729
10007235 15-deoxy-Δ12,14-Prostaglandin J2 Lipid Maps MS Standard 87893-55-8 ≥97% 2009-01-16 50.900269337017 15-deoxy-12-14-prostaglandin-j2-lipid-maps-ms-standard 15-deoxy-Δ12,14-PGJ2 PPARγ PPARgamma prostaglandins 15-deoxy-delta12,14-PGJ2 15-deoxy-d12,14-PGJ2 nuclear receptors 15-deoxy-Δ12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands atherosclerosis MS mass spectrometry standards 50.900269337017
160704 15-Lipoxygenase-1 (rabbit) Polyclonal Antiserum - 23.640755064456 15-lipoxygenase-1-rabbit-polyclonal-antiserum 15-LO-1; 15-LOX-1 15-LOs antibody Western blots 15-lipoxygenases blotting antisera antiserum antibodies atherosclerosis WB immunoblotting 23.640755064456
10010468 15-Lipoxygenase Inhibitor 1 Exclusive 928853-86-5 ≥98% ✓ 2008-10-23 39.612962761560 15-lipoxygenase-inhibitor-1 15-LO Inhibitor 1 15-LOs inhibitors inhibits inhibition oxidation inflammation thrombosis cancers lipoxygenases pyrimidobenzothiazine antioxidants 39.612962761560
13076 16(R)-Iloprost - ≥98% 2008-10-10 17.899029202841 16-r-iloprost prostacyclin platelet aggregation IP receptors EP vasodilation pulmonary hypertension stereoisomers inhibits inhibitors inhibition iloprosts PGI2 17.899029202841
13077 16(S)-Iloprost 74843-14-4 ≥98% 2008-10-10 17.899029202841 16-s-iloprost prostacyclin platelet aggregation IP receptors EP vasodilation pulmonary hypertension stereoisomers iloprosts inhibits inhibitors inhibition PGI2 17.899029202841
10010164 1-Octadecyl Lysophosphatidic Acid Exclusive 52977-29-4 ≥95% ✓ 2008-06-04 7.633057090239 1-octadecyl-lysophosphatidic-acid 1-Octadecyl LPA LPAs lysophosphatidic cells proliferation smooth muscles platelet aggregation neurite proteins sn-1 aggregating 7.633057090239
10010291 1-Octadecyl Lysophosphatidic Acid (sodium salt) Exclusive - >95% ✓ 2008-03-17 15.000331491712 1-octadecyl-lysophosphatidic-acid-sodium-salt 1-Octadecyl LPA (sodium salt) LPA G-proteins receptors cell proliferations smooth muscle contractions platelet aggregations cell motility EDG receptors 15.000331491712
10009431 1-Stearoyl-2-Arachidonoyl PC-d8 Exclusive - 99% deuterated product ✓ 2009-07-24 15.738204419889 1-stearoyl-2-arachidonoyl-pc-d8 SAPC-d8; 1-Stearoyl-2-Arachidonoyl Phosphatidylcholine-d8 SAPC LDL oxidation inflammation cardiovascular disease phospholipids LC/MS GC/MS deuterated deuteriums mass spectrometry MS LC-MS GC-MS standards 15.738204419889
515121 2,3-dinor-6-keto Prostaglandin F1α EIA Kit - 2006-05-23 161.747834254144 2-3-dinor-6-keto-prostaglandin-f1-eia-kit 2,3-dinor-6-keto PGF1α ELISA Kit solid plates enzymes immunoassays Prostaglandins PGI2 prostacyclin vascular myocardial infarction inhibits cyclooxygenases atherosclerosis stroke COX-2 measures kits PGF1a assays 161.747834254144
519051 2,3-dinor Thromboxane B2 EIA Kit - 97.221517212069 2-3-dinor-thromboxane-b2-eia-kit 2,3-dinor Thromboxane B2 ELISA Kit solid plates 2,3-dinor-TXB2 metabolites thromboxanes measures kits eias enzyme atherosclerosis immunoassays ELISAs assays 97.221517212069
10397 3-amino Benzamide New 3544-24-9 ≥98% 2011-10-07 4.889884728190 3-amino-benzamide 3-(Aminocarbonyl) Aniline; 3-Carboxamidoaniline poly(ADP-ribose) polymerases PARPs DNA repairs DNA strands breaks apoptosis inflammation atherosclerosis neruogenesis cancers angiogenesis signaling cellular responses inhibits inhibitor inhibition telomere shortening shortens stimulates mediated mediates PARP-mediated 4.889884728190
13221 3-hexanoyl-NBD Cholesterol - ≥98% 2009-06-05 9.322651933702 3-hexanoyl-nbd-cholesterol 3-C6-NBD Cholesterol fluorescent cholesterol NBD fluorophore membrane lipids flourescently-tagged probes 9.322651933702
9000368 3-hydroxy-3-methylglutaryl-Coenzyme A-d3 (ammonium salt) Exclusive - ≥99% deuterated product ✓ 2009-04-20 3.930939226519 3-hydroxy-3-methylglutaryl-coenzyme-a-d3-ammonium-salt HMG-CoA-d3 HMG-CoA mevalonic acid mevalonate cholesterol steroids sterols deuterateds deuterium standards GC MS LC mass spetrometry 3.930939226519
90500 3-Thiatetradecanoic Acid 116296-31-2 >98% 2004-02-06 1.244883977900 3-thiatetradecanoic-acid 3-TDA thioether myristic analogs PPAR ligands peroxisome proliferator-activated receptors oleic acids D9-desaturases .DELTA.9-desaturases DELTA9-desaturases atherosclerosis 1.244883977900
90312 4,5-dehydro Docosahexaenoic Acid - ≥98% 21.542909760589 4-5-dehydro-docosahexaenoic-acid 4,5-dehydro Cervonic Acid; 4,5-dehydro DHA w-3 fatty acids omega-3 .omega.-3 n-3 analogs acetylene 5-LO 5-lipoxygenases inhibits inhibitors 21.542909760589
13265 4-hydroxy Nonenal Alkyne Exclusive 1011268-23-7 ≥98% ✓ 2010-06-16 120.923977900552 4-hydroxy-nonenal-alkyne Click Tag™ 4-HNE alkyne lipids peroxidation inflammation neurodegeneration atherosclerosis diabetes cancers click chemistry Click Tag™ 4-HNEs alkynes IT 120.923977900552
60402 5-Lipoxygenase (human recombinant) - cell ly100,000 x g supernatant 60.035846021664 5-lipoxygenase-human-recombinant 5-LO; 5-LOX 5-LOs enzymes 5-lipoxygenases atherosclerosis 60.035846021664
10009638 5-Lipoxygenase (human recombinant) Western Ready Control - 78 kDa (His-tagged), 74 kDa (native) 2007-07-27 14.864263351749 5-lipoxygenase-human-recombinant-western-ready-control 5-LOX; 5-LO western blot WB 5(S)-HETE arachidonic acids leukotrienes rat basophilic leukemia alveolar eosinophils mast epithelial lungs blood 14.864263351749
10007820 5-Lipoxygenase (Phospho-Ser523) Polyclonal Antibody - 2006-09-13 8.060798593671 5-lipoxygenase-phospho-ser523-polyclonal-antibody 5-LO (Phospho-Ser523) Polyclonal Antibody wb western blotting blots antibodies regulation leukotrienes asthma fibrosis atherosclerosis inflammation regulating phospho-specific immunoblotting 8.060798593671
160402 5-Lipoxygenase Polyclonal Antibody - 36.132309392265 5-lipoxygenase-polyclonal-antibody 5-LO; 5-LOX 5-LOs LTA4 asthma 5-lipoxygenases leukotrienes antisera western blots blotting WB antibodies antiserum icc immunocytochemistry atherosclerosis immunoblotting ihc immunohistochemistry 36.132309392265
10007601 5α-hydroxy-6-keto Cholesterol 13027-33-3 ≥98% 2005-11-11 114.997253752999 5-hydroxy-6-keto-cholesterol 6-Oxo-3,5-diol; Cholestane-6-oxo-3β,5α-diol atherosclerosis cholesterols ozonolysis cytotoxicity metabolites ozone-oxidized lipids surfactants lungs epithelials lining fluids exposures cells bronchalveoalar lavaged homogenates inhibits inhibitors synthesis bronchial cytotoxicity toxic oxysterols hydroxycholesterol 114.997253752999
15210 6-keto Prostaglandin F1α 58962-34-8 >99% 57.938254143646 6-keto-prostaglandin-f1 6-keto PGF1α PGI2 metabolites prostaglandins 6-keto-PGF1alpha 6-keto-PGF1.alpha. atherosclerosis 57.938254143646
315210 6-keto Prostaglandin F1α-d4 - ≥99% deuterated product 17.610729281768 6-keto-prostaglandin-f1-d4 6-keto PGF1α-d4 GC/MS deuterium isotopes 6-keto-PGF1a-d4 6-keto-PGF1alpha-d4 6-keto-PGF1.alpha.-d4 internal standards prostaglandins PGFα deuterated LC/MS GC-MS LC-MS mass spectrometry d4 atherosclerosis 17.610729281768
515211 6-keto Prostaglandin F1α EIA Kit - 512.613747697974 6-keto-prostaglandin-f1-eia-kit 6-keto Prostaglandin F1α ELISA Kit solid plates 6-keto-PGF1alpha 6-keto-PGF1.alpha. prostaglandins measures kits eias atherosclerosis enzyme immunoassays ELISAs 6-keto Prostaglandin F1.alpha. EIA Kit assays 512.613747697974
10007219 6-keto Prostaglandin F1α Lipid Maps MS Standard 58962-34-8 >99% 2008-12-17 37.641591160221 6-keto-prostaglandin-f1-lipid-maps-ms-standard 6-keto PGF1α PGI2 metabolites prostaglandins 6-keto-PGF1alpha 6-keto-PGF1.alpha. atherosclerosis PGs MS mass spectrometry standards 37.641591160221
10312 8,12-iso-iPF2α-VI-1,5-lactone Exclusive - ≥98% ✓ 2009-08-07 6.812007366482 8-12-iso-ipf2-vi-1-5-lactone lactone IPF2α -I iPF2α-VI F2-iP urine lipid peroxidation plasma biomarker oxidative stress 214894-81-2 214894-83-4 6.812007366482
10007850 9,11-methane-epoxy Prostaglandin F1α 72517-81-8 >96% 2006-05-10 151.734235727440 9-11-methane-epoxy-prostaglandin-f1 9,11-Epoxymethano PGH1 prostaglandins PGs endoperoxides TXs thromboxanes prostacyclins PGH1 platelets smooth muscles analogs aggregation aorta aortic tracheas histamines coronary perfusion atherosclerosis 151.734235727440
38401 (±)9-HODE cholesteryl ester 33783-76-5 ≥98% 17.024290976059 -9-hode-cholesteryl-ester atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids esters (+/-)9-HODEs (+/-)-HODEs (+/-)HODEs racemic 17.024290976059
38406 9(R)-HODE cholesteryl ester - ≥98% 1.176058931860 9-r-hode-cholesteryl-ester atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids esters 9R-HODEs 9-HODEs 9(R)-HODEs 9(R)HODEs 1.176058931860
38410 9(S)-HODE 73543-67-6 ≥98% 18.700513022888 9-s-hode linoleic acids hydroxy oxidized 9S-HODEs 9-HODEs fatty 9(S)-HODEs 9(S)HODEs 18.700513022888
38411 9(S)-HODE cholesteryl ester - ≥98% 2.441436464088 9-s-hode-cholesteryl-ester atherosclerosis LDL oxidized lipids hydroxy fatty acids 9-HODEs esters 9S-HODEs 9(S)-HODEs 9(S)HODEs 2.441436464088
338410 9(S)-HODE-d4 - ≥99% deuterated product 17.761325966851 9-s-hode-d4 GC/MS deuterium isotopes 9-HODE-d4 standards 9S-HODE-d4 deuterated GC-MS LC/MS LC-MS 9-HODEs 9(S)-HODEs 9S-HODEs 9(S)HODES hydroxy fatty acids 9(S)HODE-d4 mass spectrometry 17.761325966851
100028 ACAT-1 Polyclonal Antibody - 2004-04-28 43.418459944751 acat-1-polyclonal-antibody Sterol O-Acyltransferase 1; Acyl-coenzyme A: Cholesterol Acyltransferase-1; Cholesterol Acyltransferase 1; SOAT1 Acyl-coenzyme A: cholesterol acyltransferase-1 esters ACAT1 atherosclerosis antibodies antisera antiserum western blots blotting wb icc immunocytochemistry ihc immunohistochemistry immunoblotting 43.418459944751
100027 ACAT-2 Polyclonal Antibody - 2004-04-26 39.954910220994 acat-2-polyclonal-antibody Sterol O-Acyltransferase 2; Acyl-coenzyme A: Cholesterol Acyltransferase-2 Acyl-coenzyme A: cholesterol acyltransferase-2 esters ACAT2 atherosclerosis antibodies antisera antiserum western blots blotting wb icc immunocytochemistry ihc immunohistochemistry immunoblotting 39.954910220994
10007686 Acetyl Podocarpic Acid Anhydride Exclusive 344327-48-6 >98% ✓ 2007-07-11 279.712375690608 acetyl-podocarpic-acid-anhydride APD receptors ABC1 ABCA1 oxysterol cholesterol LXRalpha LXR.alpha. LXRbeta LXR.beta. 7.alpha.-hydroxylase RXR retinoid agonists nuclear receptors atherosclerosis acetyls podocaysics acids anhydrides livers hormones atherosclerosis 279.712375690608
589451 AcSDKP EIA Kit - 107.352209944751 acsdkp-eia-kit N-Acetyl Ser-Asp-Lys-Pro EIA Kit; AcSDKP ELISA Kit N-Acetyl-Seryl-Aspartyl-Lysyl-Proline serine aspartamine lysine measures kits eias enzyme immunoassays ELISAs growth regulatory hormones plasma urine spi-bio spibio A05881 atherosclerosis hypertension endocrinology assays 107.352209944751
10092 Adenosine Receptor A2A Blocking Peptide - 2009-04-03 148.183895027624 adenosine-receptor-a2a-blocking-peptide A2AR blocking peptides Western blots immunoblotting ARA2A 148.183895027624
10006908 Adipogenesis Assay Kit - 2006-08-18 82.742697269485 adipogenesis-assay-kit obese obesity cells cycle differentiation inhibits inhibitors inhibition adipocytes cancers origin 3T3-L1 model drug screening adipokines endocrinology cell-based assays cell based assay cba 82.742697269485
10009381 Adipolysis Assay Kit - 2007-07-30 57.243504067748 adipolysis-assay-kit obese obesity cells cycle differentiation inhibits inhibitors inhibition adipocytes cancers origin 3T3-L1 model drug screening adipokines lipolysis 3T3L1 kits assays FFA adipocytes endocrinology cell-based assay cell based assay cba 57.243504067748
10008492 Adipose Triglyceride Lipase Blocking Peptide - 2006-06-27 8.294806629834 adipose-triglyceride-lipase-blocking-peptide ATGL; TG-hydrolase inducible PLA2-ζ; Desnutrin antibodies western blotting blots signaling signalling IHC WB formalin immunohistochemistry controls peptides proteins triglycerides energy storage mammalian adipose tissues caloric excess enzymes mobilization fatty acids catalyzes triacylglycerols diacylglycerols inhibition acylhydrolase activity diabetics pathology lung skeletal muscles testis heart brain kidney cells brown fat livers murine mouse macrophages HepG2 atherosclerosis 8.294806629834
10006409 Adipose Triglyceride Lipase Polyclonal Antibody - 2005-11-23 16.587553275453 adipose-triglyceride-lipase-polyclonal-antibody Phospholipase A2ζ; Desnutrin; ATGL antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry triglycerides energy storage mammalian adipose tissues caloric excess enzymes mobilization fatty acids catalyzes triacylglycerols diacylglycerols inhibition acylhydrolase activity diabetics pathology lung skeletal muscles testis heart brain kidney cells brown fat livers murine mouse macrophages HepG2 atherosclerosis immunoblotting 16.587553275453
19023 AH 23848 (calcium salt, hydrate) - ≥90% 2009-02-26 57.782110497237 ah-23848-calcium-salt-hydrate AH23848B AH 23848 TXBs thromboxane PGEs PGE2 receptors prostanoids TPs EP4 antagonist blockers inhibitors inhibits inhibition TXA2 platelets smooth muscle bronchial U-46619 U46619 fibroblasts cancers metastasis 81739-45-9 AH-23848 57.782110497237
10010241 AICAR 2627-69-2 >98% 2008-02-25 144.720110497237 aicar NSC 105823; Acadesine; AICA Riboside AMPK lipids metabolism glucose fatty acids sterol HMG-CoA reductases inflammation cytokine iNOS COX-2 MnSOD glia macrophages TNF-.alpha. IL-1.beta. IL-6 aminoimidazole carboxamide ribonucleotide 144.720110497237
589301 Angiotensin II EIA Kit - 154.229262218444 angiotensin-ii-eia-kit Angiotensin II ELISA Kit hypertension angiotensin measures kits eias enzyme immunoassays ELISAs spi-bio spibio A05880 atherosclerosis endocrinology assays 154.229262218444
580170 ANGPTL3 (human) EIA Kit New - 2012-01-10 120.063619661492 angptl3-human-eia-kit Angiopoietin-like protein 3 kits assays measures measurements angiopoietin-like proteins ANGPTLs angiopoietin-related growth factors AGF ligands regulated regulation angiogenesis glucose lipids energy metabolisms ANGPTL1 ANGPTL2 ANGPTL4 ANGPTL5 ANGPTL6 ANGPTL7 N-terminal N-terminus coiled-coil domains C-terminal C-terminus fibrinogen-like angiopoietins receptors Tie2 proteins Tie1 livers pro-angiogenic integrins αvβ3 endothelial cells migration adhesion inhibits inhibitors inhibition catalytic lipoproteins lipases catalyzes hydrolysis triglycerides HDL high density phospholipids hypolipidemic obese ob KK/Snk mice mouse expression hyperlipidemia atherosclerosis plasma human cholesterols immunometrics sandwich serums cultures supernatants 120.063619661492
13079 ApoAI Blocking Peptide - 2008-09-30 8.521546961326 apoai-blocking-peptide Apolipoprotein A-I; Apolipoprotein AI antibodies antibody peptides antiserum antisera blocking immunoblotting WB western blots 8.521546961326
13042 ApoAI Monoclonal Antibody (Clone CC3821C4) Exclusive - ✓ 2008-10-15 22.287753222836 apoai-monoclonal-antibody-clone-cc3821c4 Apolipoprotein AI antibodies HDL high-density lipoproteins WB western blots polypeptide immunoblotting blotting A-I A-1 apopipoproteins 22.287753222836
10008463 ApoAI Polyclonal Antibody - 2006-03-30 25.340576164167 apoai-polyclonal-antibody Apolipoprotein A-I; Apolipoprotein AI atherosclerosis proteins diseases antibodies antisera antiserum WB western blotting ICC immunocytochemistry ApoA1 ApoA-1 Apo A-1 Apo A1 Apo AI Apo-A1 Apo-AI blots immunoblotting 25.340576164167
10009751 ApoAI Western Ready Control - 2007-07-11 14.577283609576 apoai-western-ready-control Apolipoprotein AI western blots WB high-density lipoproteins HDL liver phospholipids excretion steroidogenesis blotting ApoA-1 atherosclerosis ApoA1 ApoA-I 14.577283609576
70260 Aspirin 50-78-2 >99% 12.523180568597 aspirin Acetylsalicylic Acid atherosclerosis cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits 12.523180568597
10010153 Aspirin™ Effect-Detection Kit - 2007-06-08 85.853535911602 aspirin-effect-detection-kit use:human 11-dehydro-TXB2 enzyme immunoassays ELISAs kits measures metabolites atherosclerosis thromboxanes eias analysistools:eia atherosclerosis cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits atherosclerosis assays 85.853535911602
10005292 Atherosclerosis Product Pack - 2004-09-09 4.426397790055 atherosclerosis-product-pack Acyl-coenzyme A: cholesterol acyltransferase-1 esters ACAT1 atherosclerosis inhibitors inhibits inhibition CETP WB blots blotting IHC immunohistochemistry JTT-705 89450 packs 4.426397790055
589401 Atriopeptin (rat) EIA Kit - 35.716574585635 atriopeptin-rat-eia-kit Atriopeptin (rat) ELISA Kit naturiuretic auriculin measures kits eias enzyme immunoassays ELISAs atherosclerosis pi-bio spibio A05103 hypertension endocrinology assays 35.716574585635
60924 Azelaoyl PAF - >98% 62.798729281767 azelaoyl-paf PPAR gamma oxidized LDL lipids agonist atherosclerosis nuclear receptors 62.798729281767
10010266 BAY-11-7082 19542-67-7 ≥98% 2008-07-25 28.859627455494 bay-11-7082 inhibitors inhibits inhibition NFkB NF-.kappa.B NF-kB NF-kappaB TNF.alpha. TNFa TNFalpha I.kappa.B-.alpha. IkB-a IkappaB-alpha inflammation cytokine cell adhesion ICAM-1 ICAM1 VCAM-1 VCAM1 E-selection Eselection Bay 11-7082 BAY-117821 Bay117082 BAY 117821 28.859627455494
18230 Beraprost (sodium salt) 88475-69-8 >98% 92.534682213371 beraprost-sodium-salt TRK 100; Procyclin; ML 1129 prostaglandins inhibitors inhibits PGI2 prostacyclin platelets aggregation pulmonary atherosclerosis hypertension analogs salts ML-1129 ML1129 TRK-100 TRK100 Na+ 92.534682213371
10006427 Berberine 633-65-8 >95% 2005-05-25 7.486015193369 berberine Umbellatine; BBR natural alkoloid hypocholesterolemic activity berberidaceaen medicine antiprotozoal antidiahreal agents reduces total cholesterol LDLR low-density lipoproteins triglycerides high fat diet LDL-receptors proteins mRNA levels hepatocytes serum atherosclerosis 7.486015193369
10009145 Bezafibrate 41859-67-0 >98% 2007-08-02 4.505756906077 bezafibrate Difaterol; Bezatrol; Bezalip; BM 15075; Benzofibrate PPAR PPAR.alpha. PPAR.delta. PPAR.gamma. agonist Pan-PPAR cholesterol atherosclerosis metabolic syndromes LDL HDL proliferator-activated receptors diabetes low-density high-density lipoproteins atherosclerosis cardiovascular PPARa PPARd PPARg endocrinology fibrate 4.505756906077
10010517 BIBB 515 156635-05-1 ≥98% 2008-06-16 1.292983425414 bibb-515 inhibitor inhibits inhibition BIBB515 OSC LDL 2,3-oxidosqualene cyclase cholesterol BIBB-515 1.292983425414
120114 BLT1 Receptor Polyclonal Antibody - 5.399350828728 blt1-receptor-polyclonal-antibody Leukotriene B4 Receptor 1; LTB4 Receptor 1; BLTR1 LTB4R1 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera flow cytometry immunocytochemistry icc WB western blots blotting immunohistochemistry ihc atherosclerosis immunoblotting FC 5.399350828728
100019 BLT1 Receptor Polyclonal Antiserum - 2.164530386740 blt1-receptor-polyclonal-antiserum Leukotriene B4 Receptor 1; LTB4 Receptor 1; BLTR1 C-terminus C-terminal intracellular plasma membranes whole cells LTB4R1 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera flow cytometry immunocytochemistry icc WB western blots blotting immunohistochemistry ihc chronic pancreatitis pancreatic cancers pancreas atherosclerosis immunoblotting FC 2.164530386740
120124 BLT2 Receptor Polyclonal Antibody - 104.227263068422 blt2-receptor-polyclonal-antibody Leukotriene B4 Receptor 2; LTB4 Receptor 2; BLTR2 LTB4R2 LTB4-R2 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera western blots blotting WB atherosclerosis immunoblotting 104.227263068422
10155 BM 567 284464-77-3 >98% 2005-03-31 44.169010128913 bm-567 platelets thromboxanes TXA2 atherosclerosis synthases inhibits inhibition inhibitors antagonists BM567 BM-567 thrombogenic vasocontrictors TP receptors eicosanoids strokes myocardial infarctions GPCR vascular smooth muscles protein-coupled license:liege 44.169010128913
60928 Butanoyl PAF - >98% 13.915469613259 butanoyl-paf ox-LDL signaling molecules oxLDL oxidized low-density lipoproteins PMNL polymorphonuclear leukocytes platelet-activating factors atherosclerosis 13.915469613259
60929 Butenoyl PAF - >98% 9.684519337016 butenoyl-paf ox-LDL signaling molecules oxLDL oxidized low-density lipoproteins PMNL polymorphonuclear leukocytes platelet-activating factors atherosclerosis 9.684519337016
13285 Cannabidiol dimethyl ether 1242-67-7 ≥98% 2009-05-19 12.442320441989 cannabidiol-dimethyl-ether Cannabidiol-2',6'-dimethyl ether; CBDD 15-lipoxygenases 15-LOs dioxygenase fatty acids inflammation thrombosis cancer LDL oxidation inhibitions inhibition inhibiting cannabinoids cbs synthetic 12.442320441989
18210 Carbaprostacyclin 69552-46-1 >99% 111.569453295644 carbaprostacyclin Carbacyclin; cPGI analogs vasodilation PPARs peroxisome proliferator-activated receptors PGI2 prostaglandins atherosclerosis cPGI Carbacyclin 111.569453295644
9000183 Carbaprostacyclin methyl ester Exclusive 69552-55-2 ≥98% ✓ 2010-11-29 26.930441988950 carbaprostacyclin-methyl-ester prostacyclins prostaglandins I2 PGI2 IPs PPARδ stable analog activate activation 26.930441988950
19010 Carbocyclic Thromboxane A2 74034-56-3 >98% 6.636961325967 carbocyclic-thromboxane-a2 CTA2; Carbocyclic TXA2 thromboxanes analogs TXA2 vasoconstriction CTA2 atherosclerosis 6.636961325967
13187 Cardiogenol C (hydrochloride) 671225-39-1 ≥97% 2009-02-06 3.536022099447 cardiogenol-c-hydrochloride Embryonic stem cells Differentiation Cardiomyocytes Cardiac muscle GATA-4 MEF2 Nkx2.5 3.536022099447
10005186 CAY10441 Exclusive 221529-58-4 >98% ✓ 2004-09-16 114.472375690607 cay10441 RO1138452 receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma cyclic AMP cAMP adenylate cyclase 4,5-dihydro-1H-imidazol-2-yl-4-4-isopropoxy benzyl phenylamine atherosclerosis 114.472375690607
10005913 CAY10449 Exclusive - >98% ✓ 2004-10-26 90.297145488029 cay10449 receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma adenylate cyclase cyclic AMP cAMP iloprost athersclerosis CAY 10449 90.297145488029
10006482 CAY10485 615264-62-5 >98% 2005-05-03 5.456898184688 cay10485 3,4-dihydroxy Hydrocinnamic acid (L-Aspartic acid dibenzyl ester) amide atherosclerosis antioxidants dihydrocinnamic acids LDLs low density lipoproteins cholesterols acyl-coenzyme A: cholesterol acyltransferase-1 catalyzes esters ACAT-1 ACAT-2 low density lipoproteins oxidations ACAT1 ACAT2 5.456898184688
10006452 CAY10486 615264-52-3 >98% 2005-05-09 6.148572744014 cay10486 4-Hydroxycinnamic acid (L-phenylalanine methyl ester) amide atherosclerosis antioxidants dihydrocinnamic acids LDLs cholesterols acyl-coenzyme A:cholesterol acyltransferase-1 catalyzes esters ACAT-1 ACAT-2 low density lipoproteins oxidations ACAT1 ACAT2 6.148572744014
10006480 CAY10487 778624-05-8 >98% 2005-03-29 6.148572744014 cay10487 3,4-Dihydrocinnamic Acid (L-alanine methyl ester) amide atherosclerosis antioxidants dihydrocinnamic acids LDLs cholesterols low-density lipoproteins foam cells fatty streaks arterial walls lesions thoracic aortas lipids ACAT-1 ACAT-2 ACAT1 ACAT2 6.148572744014
10007875 CAY10499 Exclusive 359714-55-9 >98% ✓ 2006-07-25 10.739373848986 cay10499 obesity lipases diabetes triglycerides diacylglycerol inhibitors steroidogenesis spermatogenesis atherosclerosis HSL hormone sensitive endocrinology 10.739373848986
10009536 CAY10512 Exclusive 139141-12-1 >97% ✓ 2007-07-18 34.858370165745 cay10512 analogs resveratrol nuclear factors NFkB NF-.kappa.B immunity inflammation stress growth apoptosis trans-stilbene activation cancers NF-kB inhibition inhibtors inhibits atherosclerosis 34.858370165745
10009017 CAY10514 868526-38-9 >98% 2007-01-24 4.201270718232 cay10514 Methyl-8-hydroxy-8-(2-pentyl-oxyphenyl)-oct-5-ynoate peroxisome proliferator-activated receptors aromatics analogs 8-HETEs 8S-HETE 8(S)-HETE agonists PPARa PPARalpha PPAR.alpha. PPARg PPARgamma PPAR.gamma.atherosclerosis 4.201270718232
16835 CAY10580 Exclusive 64054-40-6 ≥96% ✓ 2009-03-16 69.985690607735 cay10580 PGEs PGE2 receptors inhibitors inhibits inhibition antagonist blockers EP4 cAMPs bones fromation resorption cancers atherosclerosis 69.985690607735
10012424 CAY10583 Exclusive 862891-27-8 ≥98% ✓ 2009-07-21 63.720202578268 cay10583 LTB4 leukotrienes B4 LTBs BLT1 BLT2 BLTs agonist aggregation inflammation increases calcium intracellular stores induces ERK phosphorylation 63.720202578268
13181 CAY10590 Exclusive 1101136-50-8 ≥98% ✓ 2009-04-15 16.014672454617 cay10590 sPLA2 cPLA2 iPLA2 phospholipases inhibitors R-gamma-nonleucine inhibition inhibited secreetory regulates phagocytosis foam cells 16.014672454617
10012536 CAY10592 Exclusive 685139-10-0 ≥98% ✓ 2009-02-26 40.261718232043 cay10592 selective PPARδ agonist HDLs LDLs TGs lipids metanolism plasma rats L6 cells lines APOB100 CETP-Tgn mice mouse transactivation assays CETPTgn CETP Tgn 40.261718232043
13281 CAY10598 Exclusive 346673-06-1 ≥98% ✓ 2010-05-07 68.911458563535 cay10598 Prostaglandins E2 PGE2 receptors EP4 bone formation cancers atherosclerosis agonists EP1 EP2 EP3 DP FP IP TP neuroprotection renal dysfunction inflammation neuro-protection 68.911458563535
13282 CAY10599 Exclusive 1143573-33-4 ≥98% ✓ 2009-07-21 48.205131982811 cay10599 thiazolidinedione PPARs PPARγ agonist rosiglitazones BRL 49653 BRL49653 BRL-49653 diabetes TZDs 48.205131982811
10804 CAY10649 Exclusive - ≥98% ✓ 2011-04-04 18.829767549774 cay10649 5-LO leukotrienes 5-lipoxygenases inhibitors inflammation smooth muscle contraction inhibition inhibited PMNL inflammatory 18.829767549774
188150 CD36 Monoclonal Antibody (Clone JC63.1) - 22.447811304717 cd36-monoclonal-antibody-clone-jc63-1 Thrombospondin Receptor; oxLDL Receptor; Hexarelin Receptor; GPIV; GPIIIb antibodies antisera antiserum flow cytometry PPAR.gamma. CD-36 glycoprotein fatty acids PPARgamma blocking apoptosis oxidative injury atherosclerosis FC 22.447811304717
10009893 CD36 Monoclonal Antibody (Clone JC63.1) (azide free) Exclusive - ✓ 2010-03-03 21.506749539594 cd36-monoclonal-antibody-clone-jc63-1-azide-free GPIV; oxLDL; Thrombospondin Receptor; Hexarelin Receptor; GPIIIb antibodies antisera antiserum flow cytometry PPAR.gamma. CD-36 glycoprotein fatty acids PPARgamma blocking apoptosis oxidative injury atherosclerosis FC leukemia lymphocytic 21.506749539594
10009870 CD36 Monoclonal FITC Antibody (Clone JC63.1) - 2008-03-17 49.289889502762 cd36-monoclonal-fitc-antibody-clone-jc63-1 Thrombospondin Receptor; Hexarelin Receptor; GPIIIb; OxLDL Receptor; GPIV type-B atherosclerotic lesions fatty acids PPAR.gamma. expression flow cytometry immunocytochemistry FC ICC IF immunofluorescence 49.289889502762
100011 CD36 Polyclonal Antibody - 33.839622467771 cd36-polyclonal-antibody GPIIIb; GPIV; Hexarelin Receptor; oxLDL Receptor; Thrombospondin Receptor type scavengers receptors atherosclerotic lesions glycoprotiens membranes PPAR.gamma. PPARgamma antibodies atherosclerosis CD-36 western blots blotting peroxisome proliferator-activated GP-IIIb GP-IV GP-3b GP-4 WB atherosclerosis immunoblotting 33.839622467771
10010250 Cellular Retinol Binding Protein 7 Polyclonal Antibody - 2007-10-16 4.928486187845 cellular-retinol-binding-protein-7-polyclonal-antibody Retinoid Binding Protein 7; cRBP7; RET7; Cellular Retinol Acid-Binding Protein IV western blots WB ICC immunocytochemistry micronutrient cell growth differentiation CRBPs RBP4 RBP7 atherosclerosis blotting immunoblotting IHC immunohistochemistry 4.928486187845
10007171 Cetaben 55986-43-1 ≥98% 2005-11-11 1.840629834254 cetaben Hexadecylamino-p-amino Benzoic Acid clofibrate peroxisomes proliferator-activated receptors PPARalpha PPAR.alpha.-independent hypolipidemic activity reduces reduction serums triglycerides cholesterols concentrations peroxisomal enzymes inhibits synthesis hepatoma HepG2 cells reversible changes Golgi morphology blocked esters inhibitors fibrates class atherosclerosis endocrinology 1.840629834254
10012447 CG 4305 - ≥95% 2010-05-12 48.643291239147 cg-4305 antithrombotic PGI2 epoprostenol prostacyclins platelets aggregation 89955-40-8 PGs prostaglandins I2 cartoid artery thrombosis inhibits inhibited inhibition inhibitory Epoprostenol Sodium(5Z,9alpha,11alpha,13E,15S)Isomer Epoprostenol Sodium Prostaglandin I(2) Prostaglandin I2 Prostacyclin Epoprostenol Epoprostanol Flolan PGI2 PGX 48.643291239147
10325 Chemokine-Like Receptor 1 Polyclonal Antibody - 2010-01-25 67.220178023327 chemokine-like-receptor-1-polyclonal-antibody Resolvin E1 Receptor; GPCR ChemR23; ChemerinR; DEZ; CMKLR1; ChemR23 immunohistochemistry antibodies western blots WB IHC ChemerinR immunoblotting blotting DEZ ChemerinR 67.220178023327
10011286 Chenodeoxycholic Acid 474-25-9 ≥95% 2009-02-25 25.750209944751 chenodeoxycholic-acid Ulmenide; Kebilis; Anthropodeoxycholic Acid; Hekbilin; Fluibil; CDCA FXR biles acids cholesterol oxidative stress glutathione cancers atherosclerosis diabetes hyperlipidemia CDA 25.750209944751
10007640 Cholesterol Assay Kit - 2006-02-28 132.558155021223 cholesterol-assay-kit Fluorescence Kits Metabolism coronary heart diseases LDL lipoproteins ADHP atherosclerosis assays fluorescent fluorometric 132.558155021223
10009779 Cholesterol Cell-Based Detection Assay Kit - 2007-05-04 57.448908721726 cholesterol-cell-based-detection-assay-kit Fluorescence Kits Metabolism coronary heart diseases LDL lipoproteins ADHP atherosclerosis fluorescent fluorometric assays cell-based assay cell based assays cba U18666A U 18666A U-18666A 57.448908721726
600440 Cholesterol Uptake Cell-Based Assay Kit - 2011-06-28 40.420202843887 cholesterol-uptake-cell-based-assay-kit assays kits measures measurements cells hormones intermediates bile acids biosynthesis body cholesterols homeostasis de novo dietary absorption biliary clearance excretion plasma hypercholesterolemia cardiovascular diseases serum hepatic Ezetimibe inhibitors inhibits inhibition intestinal uptake enterocytes proteins Niemann-Pick C1 Like 1 NPC1L1 genes influx efflux intraluminal molecules membranes modulators NBD cultured U18666A inhibitor inhibits inhibition positive controls U 18666A U-18666A 40.420202843887
48001 Cholesteryl Linoleate Hydroperoxides - >98% hydroperoxide content 15.534154696132 cholesteryl-linoleate-hydroperoxides autoxidation atherosclerosis LDL HDL hydroperoxy fatty acids 15.534154696132
10010060 ChREBP Cell-Based Translocation Assay Kit - 2007-08-15 13.511767955800 chrebp-cell-based-translocation-assay-kit Carbohydrate Response Element-Binding Protein Cell-Based Translocation Assay Kit assays kits transcription factors TFs diabetes nutrients hormones hormonal regulation genes encoding enzymes glucose metabolisms lipogenesis dephosphorylated cytoplasm protein Ser196 nucleus liver obesity tolerance drugs discovery modulators sub-cellular localization ICC immunocytochemical stains staining antibody antibodies DyLightTM Pierce Biotechnology Inc. fluorescence fluorescent fluorometric endocrinology cell-based assay cell based assay cba 13.511767955800
10006909 ChREBP Transcription Factor Assay Kit - 2006-07-12 41.970987020959 chrebp-transcription-factor-assay-kit Carbohydrate Response Element-Binding Protein tf chrebps carbohydrate response element binding protein glucose liver insulin obesity adipokines endocrinology assays 41.970987020959
71730 Ciglitazone 74772-77-3 ≥98% 55.159568056253 ciglitazone U-63287; ADD 3878 nuclear receptors antidiabetic diabetes thiazolidinedione PPAR gamma PPAR.gamma. Peroxisome Proliferator-activated receptors Ligands Binding domains antihyperglycemic atherosclerosis endocrinology 55.159568056253
18216 Ciprostene (calcium salt) 81703-55-1 ≥98% 49.975811223178 ciprostene-calcium-salt U-61431F; Ciprostene calcium PGI2 analogs vasodilation 9.beta.-methyl 9beta-methyl carbaprostacyclin prostaglandins salts cat U61431F atherosclerosis 49.975811223178
10004235 cis-Resveratrol 61434-67-1 >98% (may contain 1-5% trans) 2008-02-05 26.492569060773 cis-resveratrol (Z)-Resveratrol antioxidant oxidative stress reactive oxygen species reactive nitrogen species ROS RNS NF-kb inflammations monoamine oxidase noradrenaline inhibits inhibitor inhibitions NF.kappa. atherosclerosis sirtuins AHR antagonists aryl hydrocarbon receptors 26.492569060773
10956 Clofibrate 637-07-0 ≥98% 2004-09-14 20.835156537752 clofibrate PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated nuclear receptors lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases homeostasis agonists selectivity atherosclerosis endocrinology fibrate 20.835156537752
160110 COX-1 Monoclonal Antibody (Clone CX111) - 41.768611878453 cox-1-monoclonal-antibody-clone-cx111 Prostaglandin H Synthase 1; Cyclooxygenase 1; PGHS-1 prostaglandins inflammation cancer arthritis antibodies cox1 pghs1 pghs-1 synthases cyclooxygenases western blots blotting WB antisera antiserum immunohistochemistry IHC immunocytochemistry ICC antisera antiserum atherosclerosis immunoblotting 41.768611878453
160109 COX-1 (mouse) Polyclonal Antibody - 35.332127071823 cox-1-mouse-polyclonal-antibody Prostaglandin H Synthase 1; Cyclooxygenase 1; PGHS-1 prostaglandins inflammation cancer arthritis antibodies mouse cox1 pghs1 pghs-1 cyclooxygenase-1 cyclooxygenases synthase-1 synthases antiserum antisera western blots blotting wb IHC immunohistochemistry atherosclerosis immunoblotting 35.332127071823
10011236 C-Reactive Protein (human) EIA Kit - 2009-04-22 295.742828729282 c-reactive-protein-human-eia-kit CRP (human) EIA Kit atherosclerosis proteins hepatocytes adipocytes plasma blood inflammatory inflammation physiological pathological atherogenesis endothelial coagulation ICAM-1 VCAM-1 E-selectin LDL macrophages plaques immunometric assays enzyme immunoassay ELISAs 295.742828729282
120500 CysLT1 Receptor Polyclonal Antibody - 55.305828729282 cyslt1-receptor-polyclonal-antibody Cysteinyl Leukotriene Receptor 1 cysteinyl-leukotrienes receptors antibodies LTC4 LTD4 LTE4 Cys-LT1 human flow cytometry asthma peptido-leukotrienes FACS antisera immunochemistry icc immunohistory ihc antiserum wb western blotting blots atherosclerosis immunoblotting immunocytochemistry immunohistochemistry FC 55.305828729282
13202 Daidzin New 552-66-9 ≥98% 2011-09-30 3.089855570539 daidzin NPI 031D; Daidzoside isoflavones soy kudzu anti-oxidants cancers oxidants stress atherosclerosis inhibitor inhibits inhibition mitochondrial aldehydes dehydrogenases 2 alcohols plants anticarcinogenic anti-carcinogenic anti carcinogenic antioxidants antidipsotropic dipsotropic anti-dipsotropic anti-atherosclerosis antiatherosclerosis atherosclerosis 1329-08-4 28572-56-7 NPI-031D NPI031D 7-glucoside glucosides 3.089855570539
10012577 Diallyl Trisulfide 2050-87-5 ≥98% 2009-04-07 21.778752608962 diallyl-trisulfide DATS; NSC 651936 garlic hydrogen sulfides H2S cancers tumors smooth muscle cholesterol atherosclerosis donors supresses colon synthesis genes expression adenocarcinomas HCT-15 cells PC-3 xenografts 21.778752608962
62237 Diphenyl-1-pyrenylphosphine 110231-30-6 ≥98% 2006-07-25 78.445125844076 diphenyl-1-pyrenylphosphine DPPP hydroperoxides oxidative stress injury fluorescence fluorescent lipids cholesterols LDL oxidation DPPPO DPPP=O atherosclerosis 78.445125844076
10005057 Docosahexaenoic Acid-d5 - ≥99% deuterated product 2005-03-16 197.526270718232 docosahexaenoic-acid-d5 DHA-d5; Cervonic Acid-d5 standards deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 retinol neuronal membranes neonatal deprivation hypertension 197.526270718232
9090310 Docosahexaenoic Acid ethyl ester 1020718-25-5 ≥98% 2009-01-15 60.476077348066 docosahexaenoic-acid-ethyl-ester DHA ethyl ester; Cervonic Acid ethyl ester fish oils anti-inflammatory antiiflammatory cardiovascular polyunsaturated fatty acids PUFAs DHAs neural tissues retina brain learning diet nutrition oxidation vision liver function muscle tone competitive inhibitors inhibits inhibition metabolism 60.476077348066
101640 DP1 Receptor Polyclonal Antibody - 2004-10-22 20.098715469613 dp1-receptor-polyclonal-antibody Prostaglandin D2 Receptor 1; PGD2 Receptor 1 isoforms prostaglandins PGs PGD2 cyclooxygenase metabolites G-protein coupled receptors GPCR cyclic cAMP Ca2+ calcium western blots blotting WB immunocytochemistry ICC immunohistochemistry IHC COX antibodies antiserum antisera atherosclerosis immunoblotting 20.098715469613
10011296 (E)-Guggulsterone 39025-24-6 ≥98% 2009-12-03 0E-12 -e-guggulsterone anti-flammatory cancers FXR bile acids LDL cholesterol antiinflammatory atherosclerosis obesity diabetes inflammation farnesoid X receptors guggul trees 0E-12
10008884 Eicosapentaenoic Acid ethyl ester 86227-47-6 ≥98% 2009-01-29 56.964121546962 eicosapentaenoic-acid-ethyl-ester EPA-EE; EPA ethyl ester fish oils anti-inflammatory anitinflammatory cardiovascular polyunsaturated fatty acids PUFAs EPAs nutrition oxidation competitive inhibitors inhibits inhibition metabolism cholesterol triglycerides insulin resistance adiponectin high fat diet high-fat TNFα 56.964121546962
100030 Endothelial Lipase Polyclonal Antibody - 2004-01-05 5.508165745856 endothelial-lipase-polyclonal-antibody EDL; EL antibodies antisera antiserum western blots blotting wb icc immunocytochemistry atherosclerosis special:month specialdiscount:15 specialstart:2008-03-01 specialend:2008-03-31 immunoblotting IHC immunohistochemistry 5.508165745856
583151 Endothelin EIA Kit - 192.590331491713 endothelin-eia-kit ET EIA Kit; Endothelin ELISA Kit atherosclerosis ET-1 vascular vasoconstriction measures kits eias enzyme immunoassays ELISAs endocrinology assays 192.590331491713
60880 eNOS (bovine recombinant) - cell lysate 100,000 x g supernatant 26.730980662983 enos-bovine-recombinant ecNOS; NOS III; Endothelial Nitric Oxide Synthase endothelial enzymes nitric oxide synthases cow atherosclerosis 26.730980662983
360880 eNOS Electrophoresis Standard - >95% 5.265469613259 enos-electrophoresis-standard ecNOS; NOS III; Endothelial Nitric Oxide Synthase standards western blots blotting gels staining WB synthases polyacrylamide NOS-3 atherosclerosis 5.265469613259
160880 eNOS Polyclonal Antiserum - 13.478342541437 enos-polyclonal-antiserum ecNOS; NOS III; Endothelial Nitric Oxide Synthase synthases Western blots cells EDRF vasculature antisera blotting WB antibodies antiserum atherosclerosis immunoblotting IP immunoprecipitation 13.478342541437
10477 EP2 Receptor Polyclonal PE Antibody - 2010-07-07 22.969714548802 ep2-receptor-polyclonal-pe-antibody Prostaglandin E2 Receptor 2; PGE2 Receptor 2 R-phycoerythrin immunofluorescent FL-2 FL2 FL 2 channels G-protein coupled G protein flow cytometry FC immunofluorescence IF EP1 EP2 EP3 EP4 cAMP smooth muscles mRNA tissues lungs placenta placenta spleen intestines kidneys sensory neurons 22.969714548802
10010019 FABP2 Polyclonal Antibody - 2007-10-02 24.779798737174 fabp2-polyclonal-antibody Intestinal-Fatty Acid Binding Protein; Fatty Acid Binding Protein 2; I-FABP WB western blots fatty acids FABPs lipophilic ligands metabolism polymorphism FABP2 IFABP obesity diabetes antibodies antiserum diabetic antisera atherosclerosis endocrinology blotting immunoblotting 24.779798737174
10233 FABP3 Monoclonal Antibody (Clone CC68) - 2009-03-20 11.731571516267 fabp3-monoclonal-antibody-clone-cc68 Cardiac FABP; Fatty acid binding protein 3; Heart fatty acid binding protein; H-FABP antibody antisera antiserum antibodies wb western blots immunoblotting small endogenous exogenous lipophilic ligands uptake metabolism cellular membranes levels intracellular trafficking substrates modulation enzymes lipid metabolic pathways cells growth differentiation antiparallel .beta. strands barrel cytosolic tissues biomarker myocardial injury infarction atherosclerosis endocrinology blotting 11.731571516267
10007614 FABP4 (human) EIA Kit - 2006-10-13 20.025249437282 fabp4-human-eia-kit Fatty Acid Binding Protein 4 (human) EIA Kit; Adipocyte FABP (human) EIA Kit; A-FABP (human) ELISA Kit; aP2 10009284 SPI-BIO spibio ELISA immunoassay enzyme A05181 FABP4 fatty acid binding protein adipocytes aP2 atherosclerosis endocrinology assays 20.025249437282
10009549 FABP4 (human recombinant) - >90% 2007-06-15 32.261976200594 fabp4-human-recombinant A-FABP; ALBP; Adipocyte-FABP; Fatty Acid Binding Protein 4; aP2; Adipocyte Fatty Acid Binding Protein cytosolic fatty acids lipophilic ligands tissues uptake metabolism intracellular trafficking lipid FABP-4 metabolic pathways cell growth differentiation bidirectional flux insulin epinephrine adipocytes atherosclerosis endocrinology 32.261976200594
9001068 FABP4 (human recombinant) FITC conjugated New - ≥95% 2011-08-23 11.593022888713 fabp4-human-recombinant-fitc-conjugated ALBP; Adipocyte-Fatty Acid Binding Protein; A-FABP; FABP4 fatty acids adipocytes obesity insulin resistence sensitivity cardiovascular disease atherosclerosis inflammation FABP-4 11.593022888713
10010463 FABP4 (human recombinant) Western Ready Control - 2007-10-23 5.691125690607 fabp4-human-recombinant-western-ready-control A-FABP; FABP4; ALBP; Adipocyte-FABP; Fatty Acid Binding Protein 4 fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis endocrinology immunoblotting 5.691125690607
10010231 FABP4 Inhibitor/Ligand Screening Assay Kit - 2007-11-01 25.819872503187 fabp4-inhibitor-ligand-screening-assay-kit aP2; Adipocyte FABP; A-FABP; Fatty Acid Binding Protein 4 fabps kits atherosclerosis assays fatty acid binding protein adipocytes aP2 cytosolic lipophilic ligands uptake metabolisms cellular membranes intracellular trafficking cells growth differentiation PPARg PPARgamma PPAR.gamma. peroxisomes proliferator-activated receptors agonists insulin genes deletion mice mouse murine chronic metabolic diseases diabetes atherosclerosis fluorescence fluorescent fluorometric endocrinology 25.819872503187
10005191 FABP4 (mouse recombinant) - >95% 2005-07-27 11.970839779005 fabp4-mouse-recombinant Adipocyte-FABP; ALBP; Fatty Acid Binding Protein 4; A-FABP protein-only protein-4 endogenous exogenous lipophilic ligands uptake metabolism intracellular trafficking lipid metabolic pathways modulation cell growth differentiation antiparallel .beta. strands barrel fat cells specific facilitate bidirectional flux insulin epinephrine proteins recombinant binding adipocytes fatty acids agonists insulin hyperinsulinemia deficiency afabp adipocytes atherosclerosis endocrinology 11.970839779005
10009676 FABP4 (mouse recombinant) Western Ready Control - 2007-04-30 6.356127992633 fabp4-mouse-recombinant-western-ready-control ALBP; Fatty Acid Binding Protein 4; Adipocyte-FABP; A-FABP fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis 6.356127992633
10004944 FABP4 Polyclonal Antibody - 2004-11-05 14.523662194159 fabp4-polyclonal-antibody Fatty Acid Binding Protein 4; aP2; A-FABP; ALBP; Adipocyte-FABP atherosclerosis adipocytes macrophages 3T3-L1 fatty acids PPAR.gamma. PPARgamma agonists insulin WB western blots blotting ICC immunocytochemistry hyperinsulinemia deficiency antibodies antiserum antisera endocrinology immunoblotting 14.523662194159
10010364 FABP5 (human recombinant) - >95% 2007-08-08 41.325348066298 fabp5-human-recombinant Keratinocyte FABP; Psoriasis-Associated FABP; Fatty Acid Binding Protein 5; Epidermal-FABP; E-FABP; DA11 FABP proteins lipophilic ligands uptake metabolism cellular membranes FABP-5 FABPs cytosolic fatty acids bladders carcinoma prostates atherosclerosis endocrinology 41.325348066298
10007433 FABP5 (mouse recombinant) - >95% 2005-07-29 8.621637368156 fabp5-mouse-recombinant Epidermal-FABP; Fatty Acid Binding Protein 5; E-FABP protein-only proteins cytosolic acids lipophilic ligands uptake metabolism cellular membranes intracellular trafficking modulation enzymes lipids metabolic pathways cells growth differentiation antiparallel B .beta. strands barrel prostates bladder carcinomas atherosclerosis endocrinology neurochemistry 8.621637368156
10010501 Farnesyl Thiosalicylic Acid 162520-00-5 ≥96% 2008-06-02 22.247108655617 farnesyl-thiosalicylic-acid Salirasib; FTS ras inhibitors inhibition inhibits cancer anti-cancer anticancer prenylation farnesylation signal transduction oncogene atherosclerosis farnesylthiosalicylic acid 22.247108655617
10005368 Fenofibrate 49562-28-9 ≥98% 2004-09-15 22.263124616329 fenofibrate PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated receptors nuclear fibrate agonists lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases atherosclerosis endocrinology 22.263124616329
70440 Filipin III 480-49-9 ≥85% 40.608740331491 filipin-iii Filipin-3 Filipin-III Cholesterol fluorescent fluorescence atherosclerosis filipin 111 40.608740331491
10010337 Fluvastatin (sodium salt) 93957-55-2 ≥98% 2008-02-27 12.292592738753 fluvastatin-sodium-salt atherosclerosis HMG-CoA reductases LDL LDL-c HDL HDL-c statin cholesterol heart disease CVD inhibitors inhibits inhibition 12.292592738753
10039 FR122047 (hydrate) - ≥98% 10.663865430150 fr122047-hydrate 130717-51-0 FR-122047 cyclooxygenases COX-1 inhibitors hydrates hydrochlorides COX1 PGHS1 PGHS-1 prostaglandin synthases inhibition inhibits selective selectivity platelet aggregation antiinflammatory atherosclerosis 10.663865430150
70540 Furegrelate (sodium salt) 85666-17-7 ≥99% 1.691731123388 furegrelate-sodium-salt U-63557A thromboxanes synthases inhibitors inhibits inhibition salts atherosclerosis 1.691731123388
10006798 GW 0742 317318-84-6 ≥98% 2007-07-25 20.800607734806 gw-0742 PPAR PPAR.beta. PPAR.delta. peroxisome proliferator activated receptor neurotoxicity agonists neuroprotection toxicity apoptosis lipids metabolism atherosclerosis endocrinology GW0742 GW-0742 20.800607734806
10009880 GW 590735 Exclusive 622402-22-6 ≥98% ✓ 2007-06-18 5.925966850829 gw-590735 PPAR PPAR.alpha. PPAR.BETA. PPAR.gamma. PPAR.delta. receptor transcription factors lipidtriglyceride TG lipoprotein VLDL ApoCIII ApoA1 HDL atherosclerosis endocrinology 5.925966850829
10008613 GW 7647 265129-71-3 ≥98% 2006-08-02 16.344001578532 gw-7647 PPAR.alpha. peroxisome proliferator-activated receptor triglycerides lipid homeostasis transcription factor fibrate atherosclerosis endocrinology GW7647 16.344001578532
10011211 GW 9578 Exclusive 247923-29-1 ≥98% ✓ 2008-05-23 22.652014449638 gw-9578 atherosclerosis PPAR.alpha. PPARalpha PPARa LDLs lipids nuclear receptors fibrates diabetes obesity peroxisome perliforetior-activated 22.652014449638
70785 GW 9662 22978-25-2 ≥98% 77.711331491712 gw-9662 GW-9662 GW9662 ligands ppar.gamma. ppargamma peroxisome proliferator-activated nuclear endocrinology receptors antagonists atherosclerosis 77.711331491712
9000497 GW 9662-d5 Exclusive - ≥99% deuterated product ✓ 2009-09-30 44.166034376918 gw-9662-d5 deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry GW-9662 GW9662 ligands ppar.gamma. γ ppargamma peroxisome proliferator-activated nuclear endocrinology receptors antagonists atherosclerosis TZDs thiaolidinediones PPARs 44.166034376918
10010559 HA-1077 (hydrochloride) 203911-27-7 ≥98% 2008-09-03 69.372228360957 ha-1077-hydrochloride Eril; Fasudil; AT-877 protein kinase inhibitors inhibits inhibition ROCK-II ROCKII PRK2 MSK1 MAPKAP-K1b vasodilation hypertension diabetes renal nephropathy cancers 105628-07-7 AT877 AT 877 hydrochloride dihydrochloride monohydrochloride HCl HA1077 HA 1077 69.372228360957
10006084 Hesperetin 520-33-2 ≥98% 2005-02-16 10.876011049723 hesperetin hesperitin hesperidin atherosclerosis citrus nutraceuticals flavonoids flavanoids hypocholesterolemic ACAT2 ACAT-2 mRNA transcription inhibits inhibition inhibitors ApoB proteins histamines azelastine atherosclerosis 10.876011049723
13354 Hexacosanoic Acid 506-46-7 ≥98% 2009-07-24 14.310587783916 hexacosanoic-acid Cerotic Acid; NSC 4205; Ceric Acid fatty acids very long chain very-long-chain peroxisomes peroxisomals disorders adrenoleukodystrophy atherosclerosis metabolic syndromes red blood cells plasma ceratinic acids cerinic cerylic n-hexacosanoic 14.310587783916
10006371 Hormone Sensitive Lipase Polyclonal Antibody - 2005-06-22 10.026906077348 hormone-sensitive-lipase-polyclonal-antibody HSL; LIPE proteins antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry ICC immunocytochemistry catalyses hydrolysis of tri- di- monoacylglycerols cholesterol esters mobilizes fatty acids primary source energy mammals enzyme expressed adipose tissues stearidonic steroidgenesis spermatogenesis foam cell formation atherosclerosis diabetic pathology human cDNA isoforms testis mRNA mouse murine macrophages testicular ram seminal vesicles triacylglycerols diacylglycerols atherosclerosis 10.026906077348
10699 HTS 01037 682741-29-3 ≥98% 2011-03-14 15.947182320442 hts-01037 adipocytes fatty acids binding proteins FABP4 AFABP A-FABP aP2 macrophages lipocytes diabetes atherosclerosis HTS-01037 HTS01037 Isomerases Amino Acid Acid Isomerases Amino Racemases Amino Acid Amino Acid Isomerases Acid Racemases Amino Amino Acid Racemases 15.947182320442
18215 Iloprost 78919-13-8 ≥97% 120.019686924493 iloprost Ciloprost agonists IP receptors vasodilator hypostensive atherosclerosis antiduretic hypertension analogs PGI2 prostaglandins prostacyclin selective selectivity pharma:21 120.019686924493
10809 Interleukin-33 (human) Monoclonal Antibody (Clone IL33305B) - 2011-06-03 0E-12 interleukin-33-human-monoclonal-antibody-clone-il33305b IL-1F11; NF-HEV; IL-33 antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay immunohistochemistry IHC immunoprecipitation IP IL 1F11 IL1F11 interleukin 33 NFHEV NF HEV 0E-12
10811 Interleukin-33 Monoclonal Antibody (Clone IL33026B) - 2011-06-02 0E-12 interleukin-33-monoclonal-antibody-clone-il33026b IL-33; NF-HEV; IL-1F11 antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay immunoprecipitation IP IL 1F11 IL1F11 interleukin 33 NFHEV NF HEV 0E-12
10810 Interleukin-33 Monoclonal Antibody (Clone IL333068A) - 2011-06-02 0E-12 interleukin-33-monoclonal-antibody-clone-il333068a IL-33; NF-HEV; IL-1F11 antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay 1F11 IL1F11 interleukin 33 NFHEV NF HEV 0E-12
10005518 IP Receptor (human) Polyclonal Antibody - 2004-10-21 23.657842234500 ip-receptor-human-polyclonal-antibody Prostaglandin I2 Receptor; Prostacyclin Receptor; PGI2 Receptor antibodies antisera antiserum western blots blotting wb prostacyclins rat PGI2 prostaglandins receptors immunoblotting atherosclerosis 23.657842234500
160070 IP Receptor (mouse) Polyclonal Antibody - 2004-05-25 22.299885819521 ip-receptor-mouse-polyclonal-antibody PGI2 Receptor; Prostacyclin Receptor; Prostaglandin I2 Receptor antibodies antisera antiserum western blots blotting wb prostacyclins rat PGI2 prostaglandins receptors atherosclerosis neurochemistry immunoblotting 22.299885819521
19021 I-SAP 133538-58-6 ≥98% 5.328176795580 i-sap Iodophenyl sulfonyl amino pinane Thromboxane A2; Iodophenyl sulfonyl amino pinane TXA2 thromboxanes ISAP pinane analogs agtagonists TP receptors atherosclerosis 5.328176795580
10011054 KB2115 Exclusive 355129-15-6 ≥98% ✓ 2008-06-10 75.182872928176 kb2115 thyroid hormones dyslipidemia LDL cholesterol statins cardiovascular disease atherosclerosis obesity 75.182872928176
62935 KDdiA-PC Exclusive 439904-34-4 >98% ✓ 2005-09-09 9.193616659583 kddia-pc CD36 ligands oxidized oxLDL low density lipoproteins particles cytotoxics pro-atherogenic phosphatidylcholines species short-chain fatty acids sn-2 scavengers receptors structural determinants binding affinity atherosclerosis 9.193616659583
62945 KOdiA-PC Exclusive 439904-33-3 >98% ✓ 2004-01-28 40.547849250197 kodia-pc oxidative injury lipids oxLDL oxidized low-density lipoproteins phosphatidylcholines CD36 CD-36 scavengers receptors binding atherosclerosis 40.547849250197
10009324 LCAT Blocking Peptide - 2007-01-03 19.841250000000 lcat-blocking-peptide Lecithin:Cholesterol Acyltransferase; Phosphatidylcholine-Sterol-O-Acyltransferase antibodies western blotting blots signaling signalling WB controls peptides proteins cholesterols acetyltransferases phospholipases catalyzes fatty acids transfers sn-2 phosphatidylcholines enzymes esters high-density lipoproteins HDL cells blood-plasma tissues ovary 19.841250000000
10009323 LCAT Polyclonal Antibody - 2007-01-03 19.349803560466 lcat-polyclonal-antibody Lecithin:Cholesterol Acyltransferase; Phosphatidylcholine-Sterol O-Acyltransferase proteins diseases antibodies antisera antiserum WB western blots blotting cholesterols acetyltransferases phospholipases catalyzes fatty acids transfers sn-2 phosphatidylcholines enzymes esters high-density lipoproteins HDL cells blood-plasma tissues ovary atherosclerosis immunoblotting 19.349803560466
10007672 LDL Receptor Blocking Peptide - 2007-05-03 9.010883977900 ldl-receptor-blocking-peptide Low-density Lipoprotein Receptor Blocking peptide; LDLR Blocking Peptide proteins diseases WB western blots blotting ICC immunocytochemistry cholesterols cells membranes lipoproteins low density receptors LDLRs glycoproteins blood regulates plasma ligands binding domains EGF O-link sugars membrane-spanning regions cytoplasmic livers hormonal controls mutations familial hypercholesterolemia atherosclerosis mouse murine N- SDS-PAGE unglycosylated HepG2 RAW 264.7 9.010883977900
10007665 LDL Receptor Polyclonal Antibody - 2006-02-15 32.157758827768 ldl-receptor-polyclonal-antibody LDLR; Low Density Lipoprotein Receptor proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry cholesterols cells membranes lipoproteins low density receptors LDLRs glycoproteins blood regulates plasma ligands binding domains EGF O-link sugars membrane-spanning regions cytoplasmic tails livers hormonal controls in vivo vitro mutations familial hypercholesterolemia atherosclerosis mouse murine N- SDS-PAGE unglycosylated HepG2 RAW 264.7 cell-based assay cell based assay cba immunoblotting 32.157758827768
10011125 LDL Uptake Cell-Based Assay Kit - 2008-04-29 40.735796633729 ldl-uptake-cell-based-assay-kit Low-Density Lipoprotein Uptake atherosclerosis cholestrols plasmas blood coronary heart diseases low-density lipoproteins kits assays assaying tools uptakes regulation 40.735796633729
10007817 Leukotriene A4 Hydrolase (human recombinant) - >90% 2005-12-14 266.375604665439 leukotriene-a4-hydrolase-human-recombinant LTA4H leukotrienes bifunctional zinc metalloenzymes converts LTB4 neutrophils chemoattractants hydrolases activity anion-dependent aminopeptidases drugs leukocytes infiltration inflammation E. coli epoxides atherosclerosis 266.375604665439
20110 Leukotriene B4 71160-24-2 ≥97% 185.740685732856 leukotriene-b4 LTB4 leukotrienes LTB4 inflammation chemotaxis atherosclerosis 185.740685732856
320110 Leukotriene B4-d4 - ≥99% deuterated product 136.455165745856 leukotriene-b4-d4 LTB4-d4 GC/MS LTB4-d4 deuterium internal standards isotopes leukotrienes GC-MS mass spectrometry LC/MS LC-MS deuterated spectroscopy atherosclerosis mass spectrometry 136.455165745856
520111 Leukotriene B4 EIA Kit - 859.795448895027 leukotriene-b4-eia-kit Leukotriene B4 ELISA Kit solid plates neutrophils 5-LOs 5-lipoxygenases LTB4 measures kits atherosclerosis eias enzyme immunoassays ELISAs leukotrienes assays 859.795448895027
10007240 Leukotriene B4 Lipid Maps MS Standard 71160-24-2 ≥97% 2009-01-14 33.215038674032 leukotriene-b4-lipid-maps-ms-standard LTB4 leukotrienes LTB4 inflammation chemotaxis atherosclerosis LTs MS mass spectrometry standards 33.215038674032
520411 Leukotriene E4 EIA Kit - 187.442589779006 leukotriene-e4-eia-kit Leukotriene E4 ELISA Kit solid plates kitrecommendation:cyslt allergy cys-LTs cysteinyl-leukotrienes atherosclerosis neutrophils LTE4 measures kits eias enzyme immunoassays ELISAs asthma cysteinyl-LTs peptido-LTs peptido-leukotrienes assays 187.442589779006
89430 Linolein Hydroperoxides - >98% (A mixture of 132 isomers) 12.845184162062 linolein-hydroperoxides trilinoleins autoxidation atherosclerosis isomers hydroperoxy fatty acids 12.845184162062
705002 Lipid Hydroperoxide (LPO) Assay Kit - 258.136655488158 lipid-hydroperoxide-lpo-assay-kit lipids peroxidation oxidative injury inflammation free radicals colorimetric hydroperoxides stress atherosclerosis assays 258.136655488158
705003 Lipid Hydroperoxide (LPO) Assay Kit (96 well) - 161.094848066298 lipid-hydroperoxide-lpo-assay-kit-96-well lipids peroxidation oxidative injury inflammation free radicals colorimetric hydroperoxides stress assays 161.094848066298
10010338 Lovastatin 75330-75-5 >98% 2008-03-03 7.727054823629 lovastatin LDL-c cholesterol HMG-CoA reductase HMGCoA statins heart diseases CVD atherosclerosis HDL-c NF-kB NF-.kappa.B TNF-.alpha. apoptosis anti-cancer mevacor Altocor mevinolin inhibits inhibitors inhibition 7.727054823629
10010339 Lovastatin Hydroxy Acid (sodium salt) Exclusive - >98% ✓ 2008-03-04 8.753784530386 lovastatin-hydroxy-acid-sodium-salt atherosclerosis LDL cholesterol HMG-CoA reductase statin heart disease CVD LDL-c HDL HDL-c inhibitors inhibits inhibition 8.753784530386
10010971 Luminex® 11-dehydro Thromboxane B2 Kit - 2008-01-24 66.014461325967 luminex-11-dehydro-thromboxane-b2-kit Luminex® 11-dehydro TXB2 Kit thromboxanes thromboxane A2 TXA2 metabolites urine in vivo measures kits luminex xMAP beads assays 66.014461325967
10010228 Lyso-PAF C-18 -d4 Exclusive - ≥99% deuterated product ✓ 2010-11-03 10.719922651933 lyso-paf-c-18-d4 PAFs platelet-activating factors deuterateds deuterium mass spectrometry MS LC/MS GC/MS LC-MS GC-MS 10.719922651933
10010497 Manumycin A 52665-74-4 ≥98% 2008-06-25 20.587458563536 manumycin-a UCF 1C; NSC 622141 farnesyltransferase inhibitors inhibits inhibition cancer antitumor anti-tumor signal transduction Ras farnesylation NF-.kappa.B NF-kB NF-kappaB 20.587458563536
90290 MEDICA 16 87272-20-6 >98% 15.463121546961 medica-16 hypolipidemic antidiabetogenic analogs fatty acids diabetes antidiabetic b,b'-hexadecanedioic nuclear receptors beta,beta-hexadecanedioic .beta.,.beta.'-hexadecanedioic VLDL decrease atherosclerosis 15.463121546961
600160 Methionine Sulfoxide Immunoblotting Kit - 2009-12-17 210.098508287293 methionine-sulfoxide-immunoblotting-kit MetO Immunoblotting Kit proteins sulfoxides oxidative modifications residues MSRs reactive oxygen species ROSs methionines oxidations reductases sulfones phagocytosis phagocytotic mitochondrias mitochondrial respirations sulfoxidations age-related diseases cellular cells IgG-containing sera Alzheimer's diseases immunoblots immunoblotting western blots blotting kits assays measures measurements detection tissues lysates semi-pure purified reducing non-reducing sample buffers SDS-PAGE rabbit serums immunizations oxidized corn MetO-DZS18 210.098508287293
10010340 Mevastatin 73573-88-3 ≥98% 2008-07-16 15.309383057090 mevastatin Statin I; NSC 281245; L 637312; Compactin; ML 236B; CS 500 atherosclerosis cholesterol HMG-CoA reductases statins heart diseases CVD LDL-c LDLc HDL-c HDLc TNF-.alpha. TNF-a TNF-alpha NF-kb NF-.kappa.B NF-kappaB apoptosis cancers cardiovascular TNF.alpha. inhibtis inhibitor inhibition HMGCoA pythium ultimum 15.309383057090
10006438 Myeloperoxidase Chlorination Assay Kit - 2009-04-14 116.387803867403 myeloperoxidase-chlorination-assay-kit MPO Chlorination Assay Kit heme peroxidases azurephilic granules leukocytes neutrophils monocytes tissues macrophages chlorides hydrogen peroxides H2O2 Cl- hypochlorous acids acute chronic vascular inflammatory diseases cardiac therapeutics cycles fluorescence fluorescent assays kits measures measurement crude cells lysates purified enzymes APF 2-[6-(4-aminophenoxy)-3-oxo3H-xanthen-9-yl]-benzoic acid hypochlorite -OCl 116.387803867403
10012600 Myricetin 529-44-2 >98% 2009-02-20 13.510534069981 myricetin NSC 407290; Cannabiscetin flavonoid antioxidant oxLDL CD36 atherosclerosis cancers JAK1 STAT3 MEK1 13.510534069981
63150 Myriocin 35891-70-4 >98% 2007-05-03 53.048342541436 myriocin Thermozymocidin; ISP-1 serine palmitoyltransferase inhibitors sphingolipids antibiotic immunosuppressants inhibition inhibited atherosclerosis 53.048342541436
13055 Naphthofluorescein 61419-02-1 ≥98% 2009-03-20 0.670534069981 naphthofluorescein CCG 8295 furin matrix metalloproteinase MTA-MMP MMP2 motility invasion cancer metastasis MMP inhibitors naphthafluorescein 0.670534069981
80230 NG,NG-dimethyl-L-Arginine (hydrochloride) 220805-22-1 >98% 22.045701657459 ng-ng-dimethyl-l-arginine-hydrochloride ADMA endogenous nitric oxide synthase inhibitors NOS renal failure preeclampsia inhibits inhibition asymmetric dimethylarginine hypercholesterolemia atherosclerosis muscular dystrophy 22.045701657459
189542 Nitrotyrosine Monoclonal Antibody - 42.101947513812 nitrotyrosine-monoclonal-antibody peroxynitrite nitric oxide superoxide oxidative injury stress Alzheimer's diseases antibodies NO western blots blotting WB nitration proteins antisera antiserum IHC immunohistochemistry immunoprecipitation IP atherosclerosis immunoblotting EIA enzyme immunoassays 42.101947513812
10009661 N-Octadecyl-N'-propyl-sulfamide - >95% 2008-04-23 5.244116022099 n-octadecyl-n-propyl-sulfamide PPAR.alpha. PPARa PPARalpha OEA satiety obesity metabolism food intake triglyceride lipids activators appetite suppression 5.244116022099
10010411 NS-304 475086-01-2 >98% 2008-04-09 39.701094532957 ns-304 ACT-293987; Selexipag prostaglandins PGI2 IP receptors inflammation MRE-269 agonists vasodilator hypotensive vascular diseases atherosclerosis hypertension analogs potent selective PGs 39.701094532957
10006782 Oleic Acid-2,6-diisopropylanilide 140112-65-8 >98% 2005-05-18 3.814729281768 oleic-acid-2-6-diisopropylanilide HDL LDL cholesterols ACAT inhibitors ODA acylCoA:cholesterol acyltransferase intracellular cholesteryl esters synthases dietary inhibits low-density liproteins high-density inhibition atherosclerosis 3.814729281768
10006529 Oleyl Anilide 5429-85-6 >95% 2005-05-18 2.416596685083 oleyl-anilide OA; Oleic Acid Anilide HDL LDL cholesterols ACAT inhibitors ODA acylCoA:cholesterol acyltransferase intracellular cholesteryl esters synthases dietary inhibits glycerides dioleoyl phenylamino propane 1,2-diols eosinophilia excessive T cell activation acute pulmonary inflammatory reactions TOS toxic oil syndrome aniline-denatured cooking oils interleukins atherosclerosis 2.416596685083
600240 Orexin 1 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - ✓ 2010-03-31 0.869820441989 orexin-1-receptor-step-reporter-assay-kit-luminescence OX1R hypercretins 1 orexins 2 A orexin-2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists 0.869820441989
600250 Orexin 2 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - ✓ 2010-03-31 1.019337016574 orexin-2-receptor-step-reporter-assay-kit-luminescence OX2R hypercretins 1 orexin 2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists 1.019337016574
34004 Oxidized Lipid HPLC Mixture - >98% for each compound 18.025524861878 oxidized-lipid-hplc-mixture ROS peroxidation LDL atherosclerosis autoxidation reactive oxygen species (+/-)9-HODEs (+/-)13-HODEs esters (+/-)15-HETEs (+/-)-HODEs (+/-)-HETEs hydroxy fatty acids racemic (+/-)HODEs (+/-)HETEs cholesteryl esters 18.025524861878
9000395 Oxy-16 Exclusive 596-94-1 >95% ✓ 2010-09-15 37.607279005524 oxy-16 20(R),22(R)-dihydroxy Cholesterol oxysterols sterols hedgehogs bone formations cardiovascular diseases inflammation macrophage antagonist oxy16 16 26649-05-8 26622-99-1 4005-81-6 15234-55-6 Hhs signalling signaling oxy 16 Besins-Iscovesco Brand of Androstanolone Besins Iscovesco Brand of Androstanolone Berenguer Infale Brand of Androstanolone beta-Hydroxy-5 beta-Androstan-3-One, 17 17 beta-Hydroxy-5 beta-Androstan-3-One 17 beta Hydroxy 5 beta Androstan 3 One 17beta-Hydroxy-5alpha-Androstan-3-One 17beta Hydroxy 5alpha Androstan 3 One Cuxson Brand of Androstanolone 5-alpha Dihydrotestosterone 5 alpha-Dihydrotestosterone 5 alpha Dihydrotestosterone 5 beta-Dihydrotestosterone 5 beta Dihydrotestosterone Dihydroepitestosterone Steroids, Catatoxic Dihydrotestosterone Catatoxic Steroids Diflucortolone Androstanolone Pregnatrienes Norpregnenes Azasteroids 5-alpha-DHT 5 alpha DHT Ro 10-7614 Ro 10 7614 Stanolone Ro 107614 Andractim Anaprotin Steroids Cholenes Gelovit 37.607279005524
70515 Ozagrel 82571-53-7 >98% 0.552209944751 ozagrel OKY-046 thromboxanes synthases inhibitors inhibits imidizoles TXAs antihypertensive inhibition atherosclerosis 0.552209944751
10011301 p38 MAPK Monoclonal Antibody (Clone 9F12) - 2008-05-22 2.238987108655 p38-mapk-monoclonal-antibody-clone-9f12 p38 Mitogen-activated Protein Kinase; p38 MAPKα serine threonine serine-threonine cell cycles development apotosis kinases stress signals cytokines gene expression western blots immunoblotting immunocytochemisty ICC WB flow cytometry signal transduction signalling signaling blotting FC 2.238987108655
10010374 p38 MAPK (Phospho-Thr180/Tyr182) Cell-Based Phosphorylation/Translocation Assay Kit - 2007-09-17 2.455406471981 p38-mapk-phospho-thr180-tyr182-cell-based-phosphorylation-translocation-assay-kit phosphorylation kits assays enzymes diseases asthma autoimmunity stress response nervous system fluorescence fluorescent fluorometric 2.455406471981
760901 PAF Acetylhydrolase Assay Kit - 86.260504143646 paf-acetylhydrolase-assay-kit PAF-AH; Lp-PLA2 PAF-AH colorimetric phospholipids atherosclerosis cytosolic extracellular platelet-activating factors PAFs enzymes analysistools:cytpafah analysistools:expafah assays paf elisa kit 86.260504143646
160603 PAF Acetylhydrolase (human) Polyclonal Antibody - 12.227679558010 paf-acetylhydrolase-human-polyclonal-antibody Platelet-activating Factor Receptor Acetylhydrolase; PAF-AH; Lp-PLA2 atherosclerosis platelet-activating factors Western blots asthma inflammation preeclampsia antisera PAFs WB antibodies antiserum blotting immunoblotting 12.227679558010
10010081 PAF Acetylhydrolase (human) Western Ready Control - 2007-05-30 5.625082872928 paf-acetylhydrolase-human-western-ready-control PAF-AH; Lp-PLA2; Platelet-activating Factor Acetylhydrolase; Lipoprotein PLA2 western blotting WB atherosclerosis factors asthma inflammation PAFs 5.625082872928
10004380 PAF Acetylhydrolase Inhibitor Screening Assay Kit - 2004-03-29 53.094659300184 paf-acetylhydrolase-inhibitor-screening-assay-kit PAF-AH Inhibitor Screening Assay Kit; Lp-PLA2 Inhibitor Screening Assay Kit platelet-activating factors hypotension inflammations allergys PAFAH atherosclerosis heart diseases measures kits inhibitors PAFs assays paf elisa kit 53.094659300184
60900 PAF C-16 74389-68-7 >98% 19.040729281768 paf-c-16 Platelet-activating Factor C-16 PAFs platelet-activating factors atherosclerosis 19.040729281768
360900 PAF C-16-d4 - ≥99% deuterated product 21.294033149171 paf-c-16-d4 Platelet-activating Factor C-16-d4 PAFs deuterium GC/MS internal isotopes deuterated PAF-C-16-d4 standards GC-MS LC/MS LC-MS mass spectrometry platelet-activating factors atherosclerosis 21.294033149171
60910 PAF C-18 74389-69-8 >97% 11.579502762431 paf-c-18 PAFs platelet-activating factors atherosclerosis 11.579502762431
10010229 PAF C-18 -d4 Exclusive - ≥99% deuterated product ✓ 2010-11-03 11.145823204419 paf-c-18-d4 PAFs platelet-activating factors atherosclerosis deuterateds deuterium mass spectrometry MS LC/MS GC/MS LC-MS GC-MS 11.145823204419
160600 PAF Receptor (human) Monoclonal Antibody (11A4, Clone 21) - 14.499767955801 paf-receptor-human-monoclonal-antibody-11a4-clone-21 Platelet-activating Factor Receptor platelet-activating factors antibodies PAFs ICC immunocytochemistry antisera antiserum flow cytometry FACS receptors atherosclerosis PAFR FC 14.499767955801
160602 PAF Receptor (human) Polyclonal Antibody - 13.685381215469 paf-receptor-human-polyclonal-antibody Platelet-activating Factor Receptor platelet-activating factors antisera PAFs antiserum antibodies flow cytometry facs immunocytochemistry icc western blots blotting wb atherosclerosis PAFR FC immunoblotting 13.685381215469
10009871 Palmitoleic Acid 373-49-9 ≥99% 2008-08-25 8.318084714549 palmitoleic-acid Palmitoleate; cis-Palmitoleic Acid; 9-cis-Hexadecenoic Acid; n-7 Palmitoleate monounsaturated fatty acids LDL HDL cholesterol diet 8.318084714549
62924 PAz-PC 117746-89-1 >98% 4.894838200473 paz-pc Azelaoyl PC; 1-Palmitoyl-2-Azelaoyl PC PPAR.gamma. PPARgamma receptors thiazolidinediones binding sites atherosclerosis 4.894838200473
10007185 PCSK9 (human) Polyclonal Antibody - 2005-11-30 19.205490660352 pcsk9-human-polyclonal-antibody Proprotein Convertase Subtilisin Kexin 9; NARC-1 atherosclerosis proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry serines proteases family lipoproteins subtilisin metabolisms mutations genes autosomal doimant dominance hypercholesterolemia low density LDLs overexpressions plasmas total cholesterols livers kidneys lungs spleens jejunums ileums colons muscles golgi tissues atherosclerosis immunoblotting 19.205490660352
10218 PCSK9 Monoclonal Antibody (Clone 15A6) - 2008-10-29 12.235893186004 pcsk9-monoclonal-antibody-clone-15a6 Proprotein Convertase Subtilisin Kexin 9; NARC-1 antibodies proproteins serine protease lipoproteins LDLs low density neural apoptosis-regulated convertase 1 blotting ligands western immunoblotting WB blots 12.235893186004
10008811 PCSK9 (mouse) Polyclonal Antibody - 2007-01-22 16.785757487642 pcsk9-mouse-polyclonal-antibody Proprotein Convertase Subtilisin Kexin 9; NARC-1 immunoblot neural apoptosis regulated convertase 1 atherosclerosis proteins antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry serines proteases lipoproteins subtilisin metabolisms mutations genes autosomal doimant dominance hypercholesterolemia low density LDLs overexpressions plasmas total cholesterols atherosclerosis PCSK-9 immunoblotting 16.785757487642
10240 PCSK9 Polyclonal Antibody - 2009-07-21 4.816482504604 pcsk9-polyclonal-antibody NARC-1; Proprotein Convertase Subtilisin Kexin 9 PCSK-9 PCSK 9 western blots ICC WB immunocytochemistry protease LDLs lipoproteins low-density low density cholesterol immunoblotting blotting 4.816482504604
10009567 PCSK9 Western Ready Control - 2007-01-31 7.991728492502 pcsk9-western-ready-control Proprotein Convertase Subtilisin Kexin 9; NARC-1 PSEC0052 subtilisin serine proteases LDLs low density lipoproteins cholesterol receptors golgi atherosclerosis 7.991728492502
10010518 PD 146176 4079-26-9 ≥98% 2009-02-25 33.724827597203 pd-146176 NSC 168807 atherosclerosis 15-LOs 15-lipoxygenases oxidant injury injuries apoptosis amyloid β proteins inhibitors inhibits inhibitions Alzheimers disease oxidative stress pd146176 33.724827597203
101707 PGC-1 Polyclonal Antibody - 2005-10-12 29.404158714214 pgc-1-polyclonal-antibody PPARγ Coactivator 1; Peroxisome Proliferator-activated Receptor γ Coactivator 1 atherosclerosis proteins diseases antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry peroxisomes receptors gamma .gamma. PGC-1.beta. PGC-1.alpha. PRC N- C-terminus inducible transcriptional nuclear energy hepatic gluconeogenesis cholesterol homeostasis activates oxidative metabolisms tissues kidneys heart brown adipose skeletal muscles metabolic disorders type II 2 diabetes obesity endocrinology immunoblotting 29.404158714214
10044 PGPC 89947-79-5 >98% 2004-01-21 7.050950276243 pgpc PPAR.gamma. PPARgamma oxidized LDL lipds agonists atherosclerosis nuclear receptors thiazolidinediones sites peroxisome low-density lipoproteins e-selectin vcam1 vcam-1 binding 7.050950276243
10009926 Phosphatidylcholine Assay Kit - 2007-07-10 54.642302025782 phosphatidylcholine-assay-kit PC Assay Kit assays kits ceramides phospholipids atherosclerosis phosphorylcholines phosphocholines glycerol cells membranes fatty acids lipoproteins homeostasis sphingomyelin SM atherosclerosis atherosclerotic lesions serums plasmas quantifying quantification colorimetric PC PLD phospholipases 54.642302025782
19020 Pinane Thromboxane A2 71111-01-8 >98% 10.440607734806 pinane-thromboxane-a2 PTA2; Pinane TXA2 Thromboxanes analogs TXA2 antagonists TP receptors atherosclerosis 10.440607734806
10031 POV-PC 121324-31-0 >98% 13.152495395948 pov-pc 2-(5-oxovaleryl) Phosphatidylcholine oxidative injury lipids stress oxLDL oxidized low-density lipoproteins CD36 CD-36 PMNLs polymorphonuclear leukocytes atherosclerosis phosphatidylcholines scavengers receptors LPS-binding affinity potent structural determinant inhibits inhibition inhibitors lipopolysaccaride atherosclerosis 13.152495395948
10009088 PPARα LBD (human recombinant) - ≥90% 2006-09-13 27.630773480663 ppar-lbd-human-recombinant Peroxisome Proliferator-activated Receptor α Ligand Binding Domain peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a recombinant proteins nuclear family families ligand activated trascription factors heterodimerize retinoic acids genes expression differentiation hNUC1 FAAR PPARβ PPARδ PPARγ liver skeletal muscles brown fats hearts kidneys livers fatty acids FAAH atherosclerotic lesions NSAIDs prostaglandins PGs leukotrienes B4 LTs LTB LTB4 WY 14643 WY-14643 WY14643 hypolipidemic CoA acyl-CoA oxidase enol-CoA hydratase dehydrogenase cytochromes P450 4A amino acids 170-430 E.coli gels electrophoresis coomassie statining western blots immunoblotting WB blotting 27.630773480663
101710 PPARα Polyclonal Antibody - 24.294904849600 ppar-polyclonal-antibody Peroxisome Proliferator-activated Receptor α peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a antibodies ligands ligand-activated activates activated lipids homeostasis fatty acids FAAH NSAIDs prostaglandins PGs luekotrienes LTs LTB LTB4 WY 14643 WY-14643 WY14643 hypolipidemic drugs transcriptionally regulates regulated regulation genes enzymes proteins metabolism oxidation acyl-CoA CoA oxidase enol-CoA hydratase chains dehydrogenase transports cytochrome P450 4A isoenzymes northern blots blotting immunoblotting liver skeletal muscle hearts kidney amino acids Atherosclerosis 24.294904849600
10006915 PPARα Transcription Factor Assay Kit - 2005-08-25 31.255970100747 ppar-transcription-factor-assay-kit Peroxisome Proliferator-activated Receptor α Transcription Factor Assay Kit peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF 31.255970100747
10008878 PPARα, δ, γ Complete Transcription Factor Assay Kit - 2006-08-22 52.032249408050 ppar-complete-transcription-factor-assay-kit PPARα PPARδ PPARγ PPAR-α PPAR-δ PPAR-γ PPAR α PPAR δ PPAR γ PPARalpha PPARdelta PPARgamma PPAR-alpha PPAR-delta PPAR-gamma delta alpha gamma PPAR.alpha. PPAR.delta. PPAR.gamma. PPAR-.alpha. PPAR-.delta. PPAR-.gamma. .alpha. .gamma. .delta.peroxisomes proliferator-activated proliferator activated receptors PPARs completes TF factors assay kits atherosclerosis endocrinology metaboli syndrome metabolism nuclear obese obesity PPAR non-radioacitve radioactive DNA detecting whole cells lysates 96-wells 96 wells immunosorbent ELISA enzyme-links enzyme-linked enzyme links linked electrophoretic mobility shifts EMSA double stranded dsDNA HRP colorimetric 52.032249408050
61700 PPARγ FL (human recombinant from E. coli) - >90% by SDS-PAGE 2007-01-10 20.984726826273 ppar-fl-human-recombinant-from-e-coli Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant) peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g human recombinant nuclear receptors ligands activated ligand-activated activates transcription factors heterodimerizes retinoic acids gene expression differentiation hormones subtypes PPARα PPARδ hNUC1 PPARβ pathology obese obesity diabetes atherosclerosis cancers adipose tissues expressed colon immune systems retina DNA binding domains binds DBD transcription factor assays 10006855 gel electrophoresis coomassie stains staining fluorescent displacement ANS rosiglitazone 20.984726826273
10009987 PPARγ FL (human recombinant from Sf21 cells) - ≥80% by SDS-PAGE 2007-06-15 58.741270718231 ppar-fl-human-recombinant-from-sf21-cells Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant from Sf21 cells) proteins binding enzymes PPAR.gamma. PPARgamma diseases obesity diabetes atherosclerosis cancers endocrinology 58.741270718231
10007685 PPARγ FP-Based Ligand Screening Assay Kit - Green - 2009-07-16 42.093284781517 ppar-fp-based-ligand-screening-assay-kit-green Peroxisome Proliferator-activated Receptor γ FP-Based Ligand Screening Assay Kit - Green peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g kits assys atherosclerosis TF diabetes drugs discovery discover endocrinology high throughput screens screening inflammations inhibitors inhibits inhibition metabolic syndromes metabolism nuclear receptors fluorescence FP-based FP based base ligands probes proteins isoforms γ1 γ2 γ-1 γ-2 1 2 adipose tissues colon immune systems retinas adipogenesis cells cellular differentiation insulin sensitization cancers fatty acids FAAH arachdionic 15-deoxy-DELTA12,14-prostaglandin 15-deoxy-DELTA12,14-PGs 15-deoxy-DELTA12,14-PGJ2 15 deoxy DELTA 12,14 PGs prostaglandins PGJ2 15-deoxy-Δ12,14-PGs 15-deoxy-Δ12,14-prostaglandins 15-deoxy-Δ12,14-PGJ2 15-deoxy-D12,14-prostaglandins 15-deoxy-D12,14-PGs 15-deoxy-D12,14-PGJ2 15-deoxy-.DELTA.12,14-prostaglandins 15-deoxy-.DELTA.12,14-PGs 15-deoxy-.DELTA.12,14-PGJ2 J2 thiazolidinediones TZD pioglitazone rosiglitazone agonists hyperglycemia hyperinsulinemia hypertriglyceridemia types 2 antidiabetics diabetes oral antagonists 42.093284781517
10007941 PPARγ LBD (human recombinant) - ≥90% 2006-03-16 18.920466543891 ppar-lbd-human-recombinant Peroxisome Proliferator-activated Receptor γ Ligand Binding Domain peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g recombinant proteins atherosclerosis diabetes endocrinology genes regulations metabolic syndrome nuclear receptors obese obesity PPAR proteins biochemistry hexahistidine-tagged tagged hexahistidine HIS-tag HIS-tagged HIS N-terminal PPARalpha PPAR.alpha. PPARα PPAR-alpha PPAR-.alpha. PPAR-α PPAR-delta PPAR-.delta. PPAR-δ PPARdelta PPAR.delta. PPARδ hNUC1 FAAR pathology diseases cancers domains LBD ligand binds binding DNA DBD RXR acid-like acid like heterodimerization thiazolidinedione rosiglitazone piolitazone insulin type II E. coli coomassie stains staining western blots blotting immunoblotting WB fluorescent 18.920466543891
71000 PPARγ Ligand Pack - >98% 64.056740331491 ppar-ligand-pack Peroxisome Proliferator-activated Receptor γ Pack ligands ppar.gamma. ppargamma receptors antagonists antidiabetic diabetes peroxisome nuclear receptors proliferator-activated 15-deoxy-delta12,14-PGJ2 rosiglitazone ciglitazone troglitazone MCC-555 MCC555 thiazolidinediones TZD GW9662 GW-9662 15-deoxy-d12,14-PGJ2 15-deoxy-.DELTA.12,14-PGJ2 nuclear receptors pioglitazone (potassium salt) 71740 18570 71742 70735 71745 10004272 GW 501516 GW501516 atherosclerosis packs 64.056740331491
101700 PPARγ Polyclonal Antibody - 14.345240726124 ppar-polyclonal-antibody Peroxisome Proliferator-activated Receptor γ peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g antibodies ligands ligand-activated activated activates activated transcription factors lipids homeostasis regulator regulates adipogenesis mRNA tissues large small intestines kidneys livers genes PPARγ1 PPARgamma1 PPAR.gamma.1 PPAR-γ1 PPAR-γ-1 PPAR-gamma1 PPAR-gamma-1 PPAR-.gamma.1 PPAR-.gamma.-1 PPAR-g-1 PPAR-g1 PPARγ1 PPARgamma1 PPAR.gamma.1 PPAR-γ2 PPAR-γ-2 PPAR-gamma2 PPAR-gamma-2 PPAR-.gamma.2 PPAR-.gamma.-2 PPAR-g-2 PPAR-g2 amino acids western blots immunoblotting blotting WB atherosclerosis endocrinology metabolism nuclear receptors 14.345240726124
10006855 PPARγ Transcription Factor Assay Kit - 2005-08-25 57.680139963167 ppar-transcription-factor-assay-kit Peroxisome Proliferator-activated Receptor γ Transcription Factor Assay Kit peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF 57.680139963167
10007451 PPARδ (human recombinant) - ≥95% 2005-07-29 11.193658686310 ppar-human-recombinant PPARβ; Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; NUC1; FAAR peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d recombinant proteins human atherosclerosis cancers EMSA electrophoretic mobility shift assays endocrinology fluorescence metabolic syndrome nuclear obese obesity biochemistry transcription factors members retionic acids genes expression developments baculovirus Sf21 heterodimerize subtypes hNUC1 FAAR ubiquitously tissues mediator embryo implantation overexpression systems gels coomassie stains staining western blots WB immunoblotting 10006914 11.193658686310
101720 PPARδ Polyclonal Antibody - 2004-11-05 18.912511300853 ppar-polyclonal-antibody Nuclear Hormone Receptor 1; NUC1; FAAR; PPARβ PPAR.delta. PPAR.beta. PPARbeta peroxisome proliferator-activated receptors PPARdelta antibodies antisera nuclear receptors antiserum western blots blotting WB ICC immunocytochemistry IHC immunohistochemistry atherosclerosis endocrinology immunoblotting antibodies 18.912511300853
10006914 PPARδ Transcription Factor Assay Kit - 2005-08-23 34.384920580110 ppar-transcription-factor-assay-kit Peroxisome Proliferator-activated Receptor δ Transcription Factor Assay Kit peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF 34.384920580110
10009568 PPARδ Western Ready Control - 2007-02-02 5.038099447513 ppar-western-ready-control Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; FAAR; PPARβ; NUC1 peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d genes families family Xenopus laevis PPARβ expressed tissues liver intestine kidney abdominal sipose skeletal muscles lipids metabolism mediator physiological functions cholesterol homeostasis embryo implantation cancers developments obese obesity 5.038099447513
10010343 Pravastatin (sodium salt) 81131-70-6 >98% 2008-03-04 12.019459352802 pravastatin-sodium-salt atherosclerosis HMGCoA HMG-CoA reductase LDL-c HDL-c statins cholesterol heart diseases CVD pravachol lipostat inhibitors inhibits inhibitions cardiovascular 12.019459352802
10011724 Propenyl-L-NIO (hydrochloride) Exclusive - >90% ✓ 2008-08-19 5.523176795580 propenyl-l-nio-hydrochloride ENIPO nitric oxide synthase NOS iNOS selective inhibitors inhibits inhibition 5.523176795580
10008841 Propylpyrazole Triol 263717-53-9 >98% 2007-01-25 77.304392265193 propylpyrazole-triol PPT 17b-estrogen 17beta-estrogen 17.beta.-estrogen receptors ERalpha ER.alpha. ERbeta ER.beta. agonist ischemia DPN diarylpropinitrile in vivo infarct endocrinology 77.304392265193
13010 Prostaglandin E1 745-65-3 >98% 54.164508901165 prostaglandin-e1 Alprostadil; PGE1 PGE1 vasodilation atherosclerosis erectile dysfunction prostaglandins pharma:1 54.164508901165
313010 Prostaglandin E1-d4 - ≥99% deuterated product 23.112504604051 prostaglandin-e1-d4 Alprostadil-d4; PGE1-d4 GC/MS deuterium isotopes PGE1-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry atherosclerosis 23.112504604051
10007939 Prostaglandin E Synthase-1 (microsomal) (human recombinant) - 16,000 x g supernatant 2009-03-15 24.408416206262 prostaglandin-e-synthase-1-microsomal-human-recombinant Membrane-Associated PGES-1; Prostaglandin H/E Isomerase; PIG12; mPGE Synthase-1; MGST1-L1 enzymes proteins PGs prostaglandins catalyzes conversion PGH2 PGE2 membrane-associated eicosanoids glutathiones metabolisms MAPEG expression proinflammatory stimuli stimulus IL-1.beta. IL-1b interleukins glucocorticoids synovial tissues primary synoviocytes rheumatiod arthritis fever onset drugs anti-inflammatory therapy therapies E. coli mPGES mPGES-1 mPGES1 24.408416206262
10009734 Prostaglandin E Synthase-1 (microsomal) Western Ready Control - 2007-05-01 8.333570441988 prostaglandin-e-synthase-1-microsomal-western-ready-control mPGE Synthase-1; PIG12; Memebrane-Associated PGES-1; Prostaglandin H/E Isomerase; MGST-L1 western blot WB prostaglandins renal failure synthase inhibitors mPGES mPGES-1 mPGES1 8.333570441988
17020 Prostaglandin H2 42935-17-1 >95% 130.696857734806 prostaglandin-h2 PGH2 PGH2 endoperoxides cyclooxygenase vasoconstrictors prostaglandins PGHS2 syntahses cox-2 cox2 PGHS-2 atherosclerosis 130.696857734806
18220 Prostaglandin I2 (sodium salt) 61849-14-7 >99% 99.961400359758 prostaglandin-i2-sodium-salt Prostacyclin (sodium salt); Epoprostenol (sodium salt); PGI2 (Na salt) PGI2 metabolites prostaglandins salts Na+ COX cyclooxygenases atherosclerosis 99.961400359758
18300 Prostaglandin I3 (sodium salt) Exclusive 68324-96-9 >99% ✓ 96.704419889503 prostaglandin-i3-sodium-salt PGI3 (Na salt) w-3 omega-3 PGI3 prostaglandins atherosclerosis .omega.-3 salts Na+ 96.704419889503
160630 Prostaglandin I Synthase Monoclonal Antibody (Clone isn-1) - Protein-A purified 5.259613259668 prostaglandin-i-synthase-monoclonal-antibody-clone-isn-1 Prostacyclin Synthase; PGIS; PGI Synthase synthases endothelium PGI2 prostaglandins antibodies antisera antiserum Bovine PGI synthase atherosclerosis neurochemistry IP immunoprecipitation IHC immunohistochemistry 5.259613259668
100023 Prostaglandin I Synthase (murine) Polyclonal Antibody - 2004-06-30 13.190704419889 prostaglandin-i-synthase-murine-polyclonal-antibody PGIS; Prostacyclin Synthase; PGI Synthase antibodies antisera antiserum western blots blotting wb IHC immunohistochemistry prostaglandins prostacyclins synthases receptors atherosclerosis immunoblotting 13.190704419889
160640 Prostaglandin I Synthase Polyclonal Antibody - 9.849760589318 prostaglandin-i-synthase-polyclonal-antibody Prostacyclin Synthase; PGIS; PGI Synthase PGIS prostacyclin synthases endothelium Western blots PGI2 prostaglandins blotting antisera antiserum immunoprecipitation IP antibodies atherosclerosis WB immunoblotting 9.849760589318
13294 Pyrrophenone 341973-06-6 ≥90% 2010-04-07 51.636966665119 pyrrophenone phospholipase A2 group IVA phospholipase A2 PLA2 cytosolic PLA2 cPLA2 arachidonic acid AA prostaglandins PG leukotrienes LT inhibitors PGE2 LTB4 blood secretory type PLA2 sPLA2 inflammation inhibition inhibits inflammatory Pyrrolidines 51.636966665119
10006217 Renin (human recombinant) - >99% by SDS-PAGE 2004-12-13 96.954689226519 renin-human-recombinant enzymes aspartyl proteases angiotensins II glycoproteins angiotensinogen salt balance hypertension angiotensinogens kidney renal preprorenin atherosclerosis endocrinology 96.954689226519
10006270 Renin Inhibitor Screening Assay Kit - 2005-05-04 73.579266080076 renin-inhibitor-screening-assay-kit Protease measurement assays aspartyl renal juxtaglomerular cells sodium depletion blood volume pressure .beta.-adrenergic stimulation angiotensinogens angiotensins I II converting ACE monomeric zinc metalloenzymes vascular endothelium messengers RAS vasoconstrictor peripheral hypertension receptors blockers fluorescence fluorescent fluorometric atherosclerosis endocrinology 73.579266080076
10012554 Resolvin D1 Exclusive 872993-05-0 ≥95% ✓ 2008-06-06 265.467516881522 resolvin-d1 RvD1; 17(S)-Resolvin D1 EPA DHA inflammation antiinflammatory anti-inflammatory immune responses aspirin LOX peritonitis LOS neurochemistry resolvins 265.467516881522
13900 Resveratrol-3-O-Sulfate 553662-69-4 ≥98% 2011-06-01 27.446250986582 resveratrol-3-o-sulfate polyphenol phytoalexin biochemicals physiological actions estrogenic antiplatelet anti-inflammatory piceid polydatin grape juices glucuronidated metabolites humans 27.446250986582
579070 Retinol Binding Protein 4 (human) Competitive EIA Kit - 2011-08-01 9.183477357510 retinol-binding-protein-4-human-competitive-eia-kit RBP4 binding proteins EIAs ELISAs enzymes immunoassays kits measures measurement insulin glucose homeostasis uptake skeletal muscles adipose tissues transporter 4 GLUT4 resistance vitamins A adipokines metabolic obesity syndromes cardiovascular diseases expression pro-inflammatory cytokines LDLs low-density lipoproteins cholesterols diet-induced obese hyperlipidemic hyperlipidemia dyslipidemia lipids metabolisms serums plasmas disorders 9.183477357510
10006415 Ro 48-8071 161582-11-2 >98% 2005-06-01 6.482817679557 ro-48-8071 monooxidosqualenes cyclases inhibitors OSC cholesterols lowering activity microsomal enzymes catalyzes lanosterol synthetic pathway LDL low-density lipoproteins human livers microsomes HepG2 cells HDL high-desity toxicity CYP3A mRNA proteins hepatocytes cultures atherosclerosis 6.482817679557
71740 Rosiglitazone 122320-73-4 >98% 141.594325177584 rosiglitazone BRL 49653 BRL49653 BRL-49653 ligands ppar.gamma. ppargamma receptors antagonists antidiabetic nuclear receptors diabetes peroxisome atherosclerosis endocrinology 141.594325177584
10011343 Rosiglitazone-d5 Maleate - >99% deuterated product 2009-04-04 40.281524861878 rosiglitazone-d5-maleate SPI TZDs thiazolinedions PPARg PPAR.gamma. PPARgamma selective ligand insulin resistance anti-inflammatory 40.281524861878
71742 Rosiglitazone (potassium salt) 316371-84-3 >98% 100.863319939728 rosiglitazone-potassium-salt BRL49653 BRL-49653 ligands ppar.gamma. ppargamma receptors antagonists antidiabetic nuclear receptors diabetes peroxisome salts thiazolidinediones atherosclerosis endocrinology 100.863319939728
10005260 Serine Palmitoyltransferase Polyclonal Antibody - 2004-12-02 28.059937384898 serine-palmitoyltransferase-polyclonal-antibody Serine-palmitoyl-CoA transferase, long chain base subunit 2; SPT antibodies antisera western blots blotting WB sphingolipids SPT2 immunohistochemistry immunohistochemical analysis IHC nuclear proteins nucleus immunoblotting 28.059937384898
10007681 Serum Retinol Binding Protein 4 Polyclonal Antibody Exclusive - ✓ 2007-08-03 3.547999999999 serum-retinol-binding-protein-4-polyclonal-antibody Plasma Retinol Binding Protein 4; pRBP; sRBP4 vitamin A wb western blotting type 2 diabetes lipocalin TTR transthyretin sRBP4 sRBP-4 proteins adipocytes signals signalling signaling insulin blots retinols serums RBP atherosclerosis endocrinology immunoblotting 3.547999999999
10010344 Simvastatin 79902-63-9 >98% 2008-02-27 20.835090765587 simvastatin MK 733 HMG-CoA reductase HMGCoA inhibits inhibitors inhibition LDL-c HDL-c statins cholesterol heart diseases CVD atherosclerosis zocor zetia exetimibe vytorin inegy TNF-.alpha. NF-.kappa.B apoptosis cancers cardiovascular NFkB atherosclerosis 20.835090765587
10010146 Soluble Epoxide Hydrolase Polyclonal Antibody - 2008-03-03 7.072434189145 soluble-epoxide-hydrolase-polyclonal-antibody Epoxide Hydrolase 2; EPHX2; sEH; Cytosolic Epoxide Hydrolase (CEH) metabolism hypertension inflammation EpETrEs EETs DiHETrEs DHET inhibitors inhibit inhibitions epoxyeicosatrienoic acids eicosatrienoic WB western blots blotting immunoblotting 7.072434189145
10006964 Sphingomyelinase Assay Kit - 2009-11-25 69.656533749699 sphingomyelinase-assay-kit SMase Assay Kit sphingomyelinases SMases hydrolases enzymes sphingolipids metabolisms DNases I superfamily sphingomyelins phosphorylcholines ceramides cells cellular stress cations lysosomal acids secreted zinc-dependent membrane-bound magnesium-dependent neutral cytosolic magnesium-independent neutral alkalines mutations ASM genes Type A B Niemann-Pick diseases physiological pathophysiological lysosomal digestion neuronal vascular ceramide-mediated signal transduction cytokine-induced apoptosis differentiation immune inflammatory lipoproteins aggregation vessel walls atherogenesis intracellular trafficking metabolism assays kits measures measuring measurements acidic activity tissues homogenates lysates serum blood saliva urine coupled enzymatic reactions oxidases betaine h2o2 hydrogen peroxides horseradish peroxidases HRPs 10-acetyl-3,7-dihydroxyphenozazine ADHP fluorescent fluorescence 69.656533749699
700330 Sphingomyelinase Inhibitor Screening Assay Kit - 2010-02-09 36.810628781899 sphingomyelinase-inhibitor-screening-assay-kit SMase assays kits measures measuring measurementsphingomyelinases SMases hydrolases enzymes sphingolipids metabolisms DNase I superfamily phosphocholines ceramides cellular cells stress pathophysiological lysosomal digestion ceramide-mediated signal transductions cytokine-induced apoptosis differentiation immune inflammatory lipoproteins aggregation vessels atherogenesis intracellular trafficking acidic neutral proliferation depressive disorders neurodegenerative disorders strokes Alzheimer's dementia diseases therapeutics cleavage conjugates free thiols 36.810628781899
19025 SQ 29,548 98672-91-4 ≥98% 87.341049723756 sq-29-548 thromboxanes TXA2 SQ-29548 SQ29548 analogs TP antagonists receptors atherosclerosis 87.341049723756
10010854 SREBP-1 Transcription Factor Assay Kit - 2008-06-24 37.029937845303 srebp-1-transcription-factor-assay-kit Sterol Regulatory Element-Binding Protein-1 Assay Kit tf atherosclerosis SREBPs sterols regulatory element binding proteins factors basic helix-loop-helix-leucine zipper family expression regulate synthesis regulation uptake cholesterol fatty acids triglycerides phospholipids adipocyte differentiation insulin-dependent genes SREBP-1a membrane-bound rough ER endoplasmic reticulum cleavage activating SREBP-Scap Golgi proteolytic two-step cleavage S1P S2P NH2 -terminal active domain nuclear localization signal importin nucleus upregulating genes fatty acids lipogenic enzymes acetyl CoA coenzymes A carboxylases synthases long chain elongases glucose glucokinases glycolysis diseases obesity diabetes mellitus insulin resistance non-alcoholic liver non-radioactive sensitve sensitivity detects detecting double stranded dsDNA extracts ELISA EMSA humans rats mouse mice murine SREBP1C SREBP 1c assays 37.029937845303
10009266 SREBP-2 Blocking Peptide - 2006-10-18 45.584171270718 srebp-2-blocking-peptide SREBF2; Sterol Regulatory Element-binding Transcription Factor 2; Sterol Regulatory Element-binding Protein-2 signaling signalling controls peptides proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry atherosclerosis 1a 1c basic helix-loop-helix bHLH transcription factors lipids homeostasis regulating genes cholesterols fatty acids metabolisms domains amino-terminals hydrophobic regions transmembranes segments carboxy regluates synthesis genes HMG-CoA reductases enzymes synthetics pathways tissues basal ER endoplasmic reticulum membranes glycosylateds nucleus cells livers brown fats testis HepG2 human fibroblasts 45.584171270718
10009239 SREBP-2 Cell-Based Translocation Assay Kit - 2007-04-17 33.036951094740 srebp-2-cell-based-translocation-assay-kit Sterol Regulatory Element-Binding Protein-2 Cell-Based Translocation Assay Kit sterol regulatory element binding proteins athersclerosis cholesterols fatty acids triglycerides phospholipids helix-loop-helix HLH transcription factors DyLight Pierce Biotechnology assays fluorescence fluorescent fluorometric cell-based assays cell based assay cba U18666A U 18666A U-18666A 33.036951094740
10007663 SREBP-2 Polyclonal Antibody - 2006-02-22 72.610157853196 srebp-2-polyclonal-antibody Sterol Regulatory Element-binding Transcription Factor 2; SREBF2; Sterol Regulatory Element-binding Protein-2 atherosclerosis proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry 1a 1c basic helix-loop-helix bHLH transcription factors lipids homeostasis regulating genes cholesterols fatty acids metabolisms domains amino-terminals hydrophobic regions transmembranes segments carboxy regluates synthesis genes HMG-CoA reductases enzymes synthetics pathways tissues basal ER endoplasmic reticulum membranes glycosylateds proteins nucleus cells livers brown fats testis HepG2 human fibroblasts endocrinology immunoblotting 72.610157853196
10007819 SREBP-2 Transcription Factor Assay Kit - 2006-09-20 38.159540937692 srebp-2-transcription-factor-assay-kit Sterol Regulatory Element-binding Protein-2 Assay Kit tf sterol regulatory element binding proteins cholesterol fatty acids triglycerides phospholipids atherosclerosis assays 38.159540937692
10009749 SREBP-2 Western Ready Control - 94 kDa (GST-tagged); 68 kDa (native) 2007-07-30 14.452685082873 srebp-2-western-ready-control Sterol Regulatory Element-binding Transcription Factor 2; Sterol Regulatory Element-binding Protein 2; SREBPF2 WB western blot helix loop bHLH fatty acids genes cholesterol regulatory HMG-CoA tissues E. coli SREBP2 SREBPF-2 transcription factors SREBP 2 atherosclerosis 14.452685082873
10011298 Stearic Acid 57-11-4 >98% 2008-10-10 19.247137303049 stearic-acid saturated fatty acids trans LDLs HDLs liporotein cholesterols dietary fats atherosclerosis 19.247137303049
10026 T0070907 313516-66-4 >98% 64.927204419889 t0070907 T-0070907 nuclear receptors antagonist PPARgamma PPAR.gamma. peroxisome proliferator-activated selective selectivity thiazolidinediones TZDs inhibits inhibition inhibitors atherosclerosis endocrinology 64.927204419889
71810 T0901317 293754-55-9 >98% 285.886132596685 t0901317 agonists to901317 TO-901317 T-0901317 t0-901317 receptors lipid nuclear hormone LXR.alpha.nuclear receptors LXR.beta. LXRalpha LXRbeta atherosclerosis 285.886132596685
10009911 Tangeritin 481-53-8 ≥98% 2008-12-16 12.446795580111 tangeritin Ponkanetin; NSC 618905; NSC 53909 flavone cancers tumors cholesterol atherosclerosis ERKs p38 MAPKs JNKs AKTs LDLs triacylglycerol estradiol MDR1 pregnane X receptors IL-1 IL1 IL 1 melanoma insulinoma 12.446795580111
10007349 TGX-221 663619-89-4 >98% 2006-02-21 21.594085766903 tgx-221 phosphatidylinositol-3-kinases PI3K catalyzes phosphorylation produces second messengers (3,4)-biphosphates -P2 (3,4,5)-P3 Class 1 p110.alpha. .beta. .delta. .gamma. p85 regulatory subunits cells permeable inhibitors inhibition inhibits ATP binding sites platelets defective thrombus formation antithrombotic therapy atherosclerosis 21.594085766903
19030 Thromboxane B2 54397-85-2 ≥99% 69.343922651933 thromboxane-b2 TXB2 thromboxanes platelets metabolites TXB2 intrarenal TXA2 urine urinary atherosclerosis 69.343922651933
160720 Thromboxane B2 11-dehydrogenase Polyclonal Antiserum - 55.899392265193 thromboxane-b2-11-dehydrogenase-polyclonal-antiserum TXB2 11-dehydrogenase; ALDH1; Aldehyde Dehydrogenase; Retinal Aldehyde Dehydrogenase Western blots blotting erythrocyte thromboxanes TXB2 antisera antibodies antiserum WB atherosclerosis immunoblotting 55.899392265193
319030 Thromboxane B2-d4 - ≥99% deuterated product 24.554217311234 thromboxane-b2-d4 TXB2-d4 GC/MS deuterium isotopes internal standards GC-MS LC/MS LC-MS mass spectrometry atherosclerosis prostaglandins TXB2-d4 thromboxanes deuterated 24.554217311234
519031 Thromboxane B2 EIA Kit - 398.476127071822 thromboxane-b2-eia-kit solid plates TXB2 thromboxanes measures kits eias enzyme atherosclerosis immunoassays ELISAs assays 398.476127071822
10004023 Thromboxane B2 Express EIA Kit - Monoclonal - 2004-07-02 106.200492987674 thromboxane-b2-express-eia-kit-monoclonal TXB2 Express ELISA Kit - Monoclonal; TXB2 Express EIA Kit (Monoclonal) solid plates atherosclerosis thromboxanes measures kits eias enzyme immunoassays ELISAs intrarenal TXA2 synthesis fast same-day assays 106.200492987674
10007237 Thromboxane B2 Lipid Maps MS Standard 54397-85-2 ≥99% 2009-01-16 15.733351749539 thromboxane-b2-lipid-maps-ms-standard TXB2 thromboxanes platelets metabolites TXB2 intrarenal TXA2 urine urinary atherosclerosis MS mass spectrometry standards 15.733351749539
19990 Thromboxane B3 71953-80-5 >98% 4.795856353591 thromboxane-b3 TXB3; Δ17-TXB2 .DELTA.17-TXB2 Thromboxanes TXB3 TXA3 omega-3 .omega.-3 w-3 d17-TXB2 DELTA17-TXB2 atherosclerosis 4.795856353591
160715 Thromboxane Synthase Polyclonal Antibody - 12.191049723757 thromboxane-synthase-polyclonal-antibody TX Synthase prostaglandins PGH2 platelet aggregation thromboxanes TXS Synthases western blots blotting WB antibodies antisera antiserum IHC immunohistochemistry atherosclerosis immunoblotting 12.191049723757
10005263 TOFA 54857-86-2 >98% 2004-07-28 51.688232044199 tofa RMI 14514; 5-(Tetradecyloxy)-2-Furoic Acid inhibits inhibitors inhibition ACC acetyl-CoA carboxylases fatty acid synthases synthesis FAS cerulenin apoptosis cancer C75 malonyl-CoA atherosclerosis endocrinology 51.688232044199
10004452 TP Receptor (human) Polyclonal Antibody - 2004-04-01 123.749331491713 tp-receptor-human-polyclonal-antibody TXA2 Receptor; Thromboxane A2 Receptor thromboxanes platelets metabolites TXA2 IHC immunohistochemistry antibodies antisera antiserum western blot blotting WB atherosclerosis immunoblotting ICC immunocytochemistry 123.749331491713
10012559 TP Receptor (human) Polyclonal FITC Antibody - 2008-07-25 76.878041743401 tp-receptor-human-polyclonal-fitc-antibody TXA2 Receptor; Thromboxane A2 Receptor antibodies antiserum antisera thromboxane A2 TXA2 receptors flow cytometry FC IF immunofluorescence western blots blotting WB immunoblotting 76.878041743401
13044 Tranilast 53902-12-8 ≥98% 2008-08-29 76.988364640884 tranilast SB 252218; Rizaben; MK 341; Tranpro; N-(3',4'-Dimethyoxycinnamoyl)Anthranilic Acid anti-inflammatory antiinflammatory angiogenesis PGDF TGF-.beta.1 TGF.beta.1 IL-8 IL8 PGE2 TXB2 antiallergenic anti-allergenic atherosclerosis vascular disease VEGF 76.988364640884
70675 trans-Resveratrol 501-36-0 >98% 96.284525582512 trans-resveratrol (E)-Resveratrol selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis sirtuins 3,5,4'-trihydroxystilbene 3,5,4'-trihydroxy-trans-stilbene 3,5,4'-THS 3,5,4'-trimethoxy stilbene 3,5,4'-trimethoxystilbene (E)-stilbenes AHR antagonists aryl hydrocarbon receptors 96.284525582512
13130 trans-Resveratrol-d4 - ≥99% deuterated product 2009-01-14 19.032016574585 trans-resveratrol-d4 (E)-Resveratrol-d4 selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis deuterated LC/MS GC-MS LC-MS mass spectrometry deuterium sirtuins AHR antagonists aryl hydrocarbon receptors 19.032016574585
10162 Treprostinil 81846-19-7 >98% 2005-08-30 222.027567583194 treprostinil Remodulin® primary pulmonary hypertension PPH arterial vascular resistance stable analogs prostacyclins increase plasma half-life vasodilatory inhibits inflammatory cytokines inhibition inhibitors GM-CF human alveolar macrophages NF-KB NF-.kappa. translocations nucleus NF-kappaB nfkb nf-kb NF-.kappa.B atherosclerosis Tyvasos Tyvaso® 222.027567583194
71750 Troglitazone 97322-87-7 >98% 163.927613259668 troglitazone ResulinTM antidiabetic thiazolidinediones PPAR.gamma. PPARgamma ligands selective peroxisome proliferator-activated receptors diabetes TZD Resulin nuclear receptors atherosclerosis endocrinology 163.927613259668
10009085 U-18666A 3039-71-2 >95% 2007-01-19 31.620033149171 u-18666a Niemann-Pick type C NPC apoptosis neuronal death Alzheimers AD neurodegeneratives diseases trafficking unesterified ER cells membranes cateracts epilepsy Free cholesterol loading NSC 70801 Endoplasmic reticulum atherosclerosis inhibits inhibitors inhibition endosomes lysomes oxidosqualene cyclases atherosclerosis 31.620033149171
16440 U-44069 56985-32-1 >98% 254.951049723757 u-44069 9,11-dideoxy-9α,11α-epoxymethano Prostaglandin F2α; 9,11-dideoxy-9α,11α-epoxymethano PGF2α; 9,11-epoxymethano Prostaglandin H2 endoperoxides methanoepoxy PGH2 thromboxanes analogs prostaglandins U44069 TP receptors agonists atherosclerosis 254.951049723757
16450 U-46619 56985-40-1 >98% 224.070877004774 u-46619 9,11-dideoxy-9α,11α-methanoepoxy Prostaglandin F2α; 9,11-dideoxy-9α,11α-methanoepoxy PGF2α endoperoxides PGH2 thromboxanes vasoconstriction analogs TP receptors agonists U46619 atherosclerosis 224.070877004774
16465 U-51605 64192-56-9 >98% 45.699275809771 u-51605 diazo endoperoxides inhibitors U51605 analogs PGH2 PGIs synthase prostaglandins inhibits thromboxanes atherosclerosis 45.699275809771
10003 Vasoactive Eicosanoid HPLC Mixture - >98% for each compound 21.036392265193 vasoactive-eicosanoid-hplc-mixture 11-dehydro-TXB2 2,3-dinor-6-keto-PGF1.alpha. 2,3-dinor-6-keto-PGF1alpha 2,3-dinor-TXB2 12-HHTs 12(S)-HHTrEs 12-HHTrEs 12(S)HHTrEs thromboxanes prostaglandins eicosanoids mixtures 2,3-dinor-PGF1.alpha. 2,3-dinor-PGF1alpha chromatography atherosclerosis 21.036392265193
70730 Wy 14643 50892-23-4 >98% 125.024723756906 wy-14643 Pirinixic Acid activators peroxisome proliferator-activated receptors adipocytes obesity PPARalpha PPAR. nuclear receptors alpha. PPARgamma PPAR.gamma. PPARdelta PPAR.delta. atherosclerosis endocrinology wy14643 125.024723756906
18113 YM-53601 Exclusive 182959-33-7 ≥98% ✓ 2009-08-11 5.061276243093 ym-53601 squalene synthases inhibitors cholesterol triglycerides HMG-CoA reductase fibrates hyperlipidemia hypercholesterolemia lipid-lowering activities inhibitor inhibited 5.061276243093
71800 (Z)-Guggulsterone 39025-23-5 ≥98% 2009-12-01 0.167679558011 -z-guggulsterone anti flammatory cancers FXR bile acids LDL cholesterol tumors IL-6 STAT3 VEGF Akt 0.167679558011
90210 α-Linolenic Acid 463-40-1 >98% 12.737751381215 -linolenic-acid ALA fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 essential leafy green vegetables alpha-linolenic .alpha.-linolenic 12.737751381215
9000433 α-Linolenic Acid-d14 - ≥99% deuterated product 2010-09-13 7.118133824432 -linolenic-acid-d14 ALA-d14 fatty acids PUFAs omega-3 ω-3 polyunsaturated essential leafy green vegetables deuterium deuterateds GC/MS GC-MS LC/MS LC-MS mass spectrometry MS signalling standards alpha-linolenic α-linolenic signaling ALAS α-linolenic 7.118133824432
16460 Δ17-U-46619 - >98% 76.384939387437 -17-u-46619 d17-u-46619 delta17-u-46619 .delta.17-u-46619 thromboxanes TXA3 analogs agonists d17-u46619 delta17-u46619 .delta.17-u46619 atherosclerosis 76.384939387437
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?